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Abstract 
 
Alexander P. Schlesinger: Protein NMR in Insect and Bacterial Cells 
(Under the direction of Gary J. Pielak, Ph.D.) 
 
Proteins perform their functions in cells where macromolecular solutes can 
reach concentrations of >300 g/L and occupy >30% of the volume. The volume 
excluded by these macromolecules will stabilize globular proteins because the 
native state of a globular protein occupies less space than the denatured state. 
The idea that volume exclusion should fold globular proteins is tested in 
Escherichia coli by using protein L Kx7E, a 7-kDa unstable globular protein 
variant of wild-type protein L. This variant requires high concentrations of 
monovalent salts to fold. The standard unfolding free energy of Kx7E in the 
absence of NaCl is -1.0 kcal/mol as determined by using in vitro 1H-15N nuclear 
magnetic resonance spectroscopy. In-cell nuclear magnetic resonance 
spectroscopy with 19F-labeled Kx7E is used to show that the crowded cytoplasm 
of E. coli cannot overcome even this modest free energy deficit and fold the 
variant. The data are consistent with the idea that non-specific interactions 
between cytoplasmic components can overcome the excluded volume effect. 
Evidence for these interactions is provided by the observation that adding simple 
salts folds Kx7E in dilute solution, but increasing the salt concentration inside E. 
coli does not fold the variant.  
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An attempt was made to acquire nuclear magnetic resonance spectra of 
the intrinsically disordered protein α-synuclein and the green fluorescent protein 
inside insect cells. Infection of Spodoptera frugiperda insect cells with 
recombinant baculoviruses containing a late basic protein promoter produces 
sufficient recombinant protein while maintaining cell viability for spectral 
acquisition. However, incorporation of the nuclear magnetic resonance active 
isotopes 15N or 19F into the recombinant proteins through the addition of 15NH4Cl 
or 5-fluorotryptophan to the cell culture media proved unsuccessful. The similarity 
of the spectra for α-synuclein, green fluorescent protein, and a fusion protein 
suggests isotope incorporation into intracellular metabolites. Thus, protein 
nuclear magnetic resonance spectra cannot be acquired in insect cells by using 
these experimental conditions. 
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Chapter 1 
Macromolecular Crowding 
 
1.1   Macromolecular Crowding Changes Protein Properties 
Almost all protein studies have been conducted in dilute solutions where 
the total concentration of macromolecules is less than 10 g/L. Proteins, however 
perform their biological functions in cells where macromolecules are present at 
hundreds of g/L and occupy about 30% of the available volume (1-4).  
The effect of high concentrations of macromolecules on equilibrium 
properties arises from two phenomena. The first, excluded volume, is the result 
of the impenetrable nature of atoms. The volume excluded by the crowding 
molecules is unavailable to the test protein. The native, folded state of a globular 
protein takes up less space than the denatured state. Application of Le 
Chatelier’s principle leads to the conclusion that volume exclusion always favors 
the native state because it occupies less space (5). 
The other phenomenon involves chemical interactions, which can be 
specific or non-specific. If the crowding molecule interacts with only the native 
state, the effect is stabilizing. If the crowder has an affinity for protein surface in 
general, however, the effect is destabilizing. The opposing chemical effects are 
reminiscent of ligand binding and urea denaturation. Ligand binding pulls the 
equilibrium between the native and denatured state toward the native state 
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because the crowder binds this state. Urea pulls the equilibrium toward the 
denatured state because the denatured state exposes more surface area. 
Although high concentrations of urea also introduce an excluded volume effect, 
this contribution is smaller than that from chemical interactions with the 
denatured state (6). Thus, one cannot know, a priori, how macromolecular 
crowding will affect globular protein stability. 
Predictions from theory suggest this excluded volume will cause large 
changes in protein properties, including structure, folding rate, equilibrium 
constants of association, and reaction equilibria (1), compared to dilute solutions. 
Macromolecular crowding is also expected to affect biological function (7, 8). For 
example, crowding-induced reduction of protein diffusion is expected to reduce 
the rate of diffusion-limited interactions, thus potentially affecting metabolic 
pathways (1). Additionally, crowding is predicted to enhance the collapse of 
polypeptide chains into functional proteins and assist in the assembly of 
oligomeric structures (1). 
Experiments support these predictions both in vitro (8-14) and in cells (2, 
15-19). DNA polymerase is functional under an extended range of inhibitory 
conditions in the presence of in vitro crowders due to increased binding of the 
polymerase to DNA (20, 21). Studies in cells show that the disordered part of 
FlgM gains structure in Escherichia coli (17), and these structural changes 
suggest that the protein has a low inherent stability which may affect its transport 
into the extracellular medium (22). 
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1.2   Macromolecular Crowding Should be Studied in Cells 
With the exception of a few in-cell studies (17-19, 23-28), most of the 
information about macromolecular crowding effects on proteins comes from in 
vitro crowding studies which are often conducted by using a single synthetic 
crowder with limited polydispersity (29). Cells, however, contain many different 
proteins, nucleic acids, and other macromolecules of different sizes, interactions, 
and localizations within the cytoplasm (30, 31). 
The complexity in cells contributes to the macromolecular crowding effect 
and can alter protein properties compared to in vitro crowded solutions. In vitro 
experiments attempting to probe the complexity of macromolecular crowding in 
cells, including differences in macromolecule sizes and localizations, show that 
these factors affect protein properties. For example, a model cytoplasm 
separated into two protein phases was demonstrated to differentially distribute 
newly introduced proteins and nucleic acids (31). A simulation comprising 50 of 
the most abundant macromolecules in E. coli at physiological concentrations, 
and representing 85% of the characterized cytoplasmic contents by weight, 
demonstrated changes in protein stability compared to values calculated by 
volume exclusion alone (32). These results suggest that effects in addition to 
volume exclusion must be considered when studying proteins in vivo. In another 
study, denatured RNase A refolded into a native-like structure in the presence of 
high concentrations of 20 kDa polyethylene glycol (PEG) but did not refold with 
0.2 kDa PEG (14), suggesting that size plays a role in macromolecular crowding. 
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Despite the useful information from in vitro experiments, some protein 
properties cannot be explored in vitro, arguing for protein study in cells. Elowitz et 
al. showed that the diffusion coefficient of the green fluorescent protein (GFP) in 
E. coli is 11 times less than that in water (2), but only 3 times less using in vitro 
protein crowder concentrations comparable to the total cellular protein 
concentration (200 g/L) (33). In another experiment, the reduced form of 
lysozyme was unable to refold properly in the presence of in vitro crowded 
solutions (12). However, reduced lysozyme refolds efficiently in cells, indicating 
that additional factors contribute to macromolecular crowding in cells such as 
chaperones which assist in protein folding (1). 
Furthermore, cells are not just crowded bags of molecules, but are highly 
organized, which aids in cellular functions (34). For example, the five enzymes 
involved in converting D-mandelate to benzoate in Pseudomonas putida were 
shown to form a complex in cells (35). Glycosomal enzyme complexes were 
purified from the protist Trypanosoma brucei by cross-linking with reagents that 
span just 11-12 Å, suggesting that the enzymes are in close proximity and 
possibly explaining the high rate of glycolysis in this organism (36). Additionally, 
fluorescence microscopy experiments show colocalization of enzymes involved 
in purine synthesis in HeLa cells (37).  
It is important to study proteins under physiologically relevant conditions to 
gain physiologically relevant data. Because of the difficulty mimicking the 
crowded cellular environment in vitro, studying proteins directly in cells or in 
lysates provides the best way to obtain physiologically relevant protein 
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information. These studies highlight differences in protein properties in cells 
versus in vitro crowded conditions and argue for the study of proteins in cells. 
1.3   NMR is Ideally Suited to Study Macromolecular Crowding in Cells 
Some techniques exist for studying protein properties both in vitro and in 
vivo, but most of them are unsuitable for direct study of proteins in live cells. A 
common method is to attach a reporter molecule, such as GFP, to the protein of 
interest. The reporter molecule provides a convenient means of detection, but 
potentially alters properties such as stability and diffusion. Other techniques like 
analytical ultracentrifugation provide information about proteins in solution but 
cannot be used to study these properties in live cells.   
Nuclear magnetic resonance (NMR) spectroscopy is a noninvasive 
technique that provides a wide range of atomic resolution information about 
macromolecules in aqueous solutions or under physiologically relevant, in-cell or 
in vitro, conditions (23). "In-cell NMR spectroscopy" (23, 38) is the observation of 
macromolecules directly in living cells. In-cell NMR has been used to determine 
protein structure (17, 39, 40), post-translational modification (27, 41), signal 
transduction (42), and binding (43, 44). Requirements for acquisition of high 
resolution protein in-cell spectra include high protein concentration (39, 45), the 
absence of test protein leakage from the cells (46), cell viability over the course 
of the experiment, and isotopic enrichment of the test protein (39, 47). 
Common in-cell NMR experiments in E. coli include the 1H-15N 
heteronuclear single-quantum coherence (HSQC) experiment, as implemented 
by the Dötch group (23). In cells, this experiment is limited to disordered proteins. 
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Globular proteins are not observable, probably due to restricted rotational motion 
in E. coli (48, 49). 19F NMR, a more sensitive technique (50, 51), is also used for 
protein in-cell NMR experiments. Brindle et al. demonstrated incorporation of 19F 
containing amino acids into 3-phosphoglycerate kinase in yeast cells (24). 19F 
NMR has also been used with success in E. coli, and its greater sensitivity allows 
detection of globular proteins in these cells (52). 
In this dissertation, in-cell NMR is utilized to study proteins inside of live 
cells. In Chapter 2, the fold of an unstable globular protein is assessed in E. coli 
cells. The standard unfolding free energy of this unstable globular protein is 
determined in dilute solution. These two pieces of information are used to answer 
the question whether the cytoplasm can provide the free energy required to fold 
the protein. Chapter 3 describes the development of an insect expression system 
optimized for in-cell NMR. Quantification of recombinant protein yields, 
optimization of cell viability, formulation of insect media for isotopic labeling of 
recombinant proteins, and NMR results are presented.  
  
Chapter 2 
Macromolecular Crowding Fails to Fold a Globular Protein in Bacteria 
 
2.1   Introduction 
 Until recently, the stabilization afforded by volume exclusion was thought 
to dominate both in vitro and in cells, although there were hints of compensation 
(15, 16, 32). Wang et al. have shown that non-specific, non-covalent interactions 
between crowder proteins and a test protein can compete with excluded volume 
effects to affect diffusion (48). Here, this idea is tested in terms of protein stability 
in crowded in vitro solutions and in Escherichia coli. 
The Immunoglobulin G binding domain of protein L from Streptococcus 
magnus was chosen as the test protein. Ever since its introduction (53), Protein L 
(ProtL) has been used as a model for globular protein folding (54). This well 
studied 7-kDa protein exhibits reversible unfolding at 25 ° C in dilute solution via 
a two-state reaction with a stability of 4.3 kcal/mol (55). Changing seven of its 
lysine residues to glutamic acids lowers the stability to -0.4 kcal/mol, such that 
the majority of the protein molecules are in the denatured state in dilute buffer. 
The destabilization arises from the variant’s decreased hydrophobic surface 
area, not the increase in negative charge (55). This Kx7E variant, however, folds 
on adding sodium (55) or potassium (see 2.3.6). If excluded volume effects 
dominate the crowding effect, then the fraction of the variant molecules in the
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native state should increase in cells relative to dilute solution. This idea was 
tested by using NMR. 
2.2   Materials and Methods 
2.2.1   Minimal Media Formulations 
15N-Enriched Minimal Media 
One L of 15N-enriched minimal medium is prepared by adding 100 mL of 
10x salts (60 g/L Na2HPO4, 30 g/L KH2PO4, 5 g/L NaCl, and 7 g/L 15NH4Cl 
[Cambridge Isotope Laboratories, Inc.; Andover, MA], pH 7.0), 1 mL of 1 mg/mL 
thiamine HCl, 2 mL of 1 M MgS04, 10 mL of a 20% (v/v) glucose solution, and 1 
mL of 100 mg/mL ampicillin to deionized water and diluting to 1 L. The ampicillin 
solution was sterile filtered with 0.22 µm polyvinylidene difluoride (PVDF) filters 
(EMD Millipore; Billerica, MA). All other solutions were sterilized by autoclaving 
for 20 min in a Sterilmatic Sterilizer (Market Forge Industries, Inc.; Everett, MA) 
set to the liquid cycle. An unenriched form of this minimal medium was prepared 
as described above but with the addition of NH4Cl instead of 15NH4Cl. Unless 
otherwise noted, all chemicals are from Thermo Fisher Scientific, Inc. (Fair Lawn, 
NJ). 
19F-Labeled Minimal Media 
One L of 19F-labeled minimal media is prepared as described for 15N-
enriched minimal media with the addition of 0.5 g N-(phosphonomethyl)-glycine, 
60 mg L-phenylalanine, 60 mg L-tryptophan, 70 mg m-fluoro-D,L-tyrosine (3-FY), 
and 10 mg biotin (Thermo Fisher Scientific, Inc.; Fair Lawn, NJ). Unless 
otherwise noted, the above components are from Sigma-Aldrich Co. (St. Louis, 
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MO). Unlabeled tyrosine minimal media were prepared with an unenriched 10x 
salts solution and L-tyrosine instead of 3-FY. The osmolality is 0.16 Osm as 
determined with a Vapro 5520 Vapor Pressure Osmometer (Wescor, Inc.; Logan, 
UT). Hyperosmotic media (56) were formulated by adding NaCl to a final 
concentration of 0.5 M in 19F-labeled minimal media. The pH value was 
readjusted to 7.0 with 8 M NaOH. The osmolality is 1.05 Osm as determined with 
the vapor pressure osmometer. 
2.2.2   ProtL Production 
pET-15b ProtL Vector Transformations  
Four pET-15b vectors (EMD Biosciences, Inc.; San Diego, CA [Fig. 2.1]) 
containing the wild-type ProtL gene or the ProtL variants Kx6Q, Kx6E, or Kx7E 
were provided by Xavier Tadeo of the Millet lab in the Structural Biology Unit of 
the Centro de Investigación Cooperativa bioGUNE, 48160 Derio, Spain. The 
vectors were transformed into BL21(DE3) Escherichia coli cells (Agilent 
Technologies, Inc.; Cedar Creek, TX), streaked onto Luria broth (LB; 1% [w/v] 
Bacto Tryptone [BD; Franklin Lakes, NJ], 0.5% [w/v] yeast extract [Thermo 
Fisher Scientific, Inc.; Fair Lawn, NJ], and 1% [w/v] NaCl) plates containing 100 
µg/mL ampicillin (LBAMP), and incubated overnight at 37 ° C.  
15N Enrichment and 19F Labeling of ProtL 
Single colonies were used to inoculate 100-mL liquid cultures of LBAMP. 
The cultures were incubated for 12-16 h at 37 ° C with  225-rotations per minute 
(rpm) shaking. The cultures were centrifuged in a Sorvall RC-5B centrifuge with a 
Sorvall GSA rotor (Thermo Fisher Scientific, Inc.; Waltham, MA) at 4,000 rpm for 
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30 min at 25 ° C. The supernatants were decanted, and  the pellets resuspended 
in 1 L of 15N-enriched minimal media, 1 L of 19F-labeled minimal media, or 1 L of 
hyperosmotic media. The cultures were incubated at 37 ° C with 225-rpm 
shaking. The inducer, isopropyl-β-D-1-thiogalactopyranoside (IPTG, 1 mM final 
concentration; Thermo Fisher Scientific, Inc.; Fair Lawn, NJ), was added when 
the cultures reached an optical density at 600 nm (OD600) of 0.6 in 15N-enriched 
minimal media or 0.8 in 19F-labeled minimal media and hyperosmotic media. The 
induced cultures were incubated at 37 ° C with 225-rpm shaking for 4 h in 15N-
enriched minimal media or 20-24 h in 19F-labeled minimal media and 
hyperosmotic media. As a control, E. coli without an expression vector were 
grown to an OD600 of 0.6 in 15N-enriched minimal media and then incubated for 
an additional 4 h. 
Cultures were prepared for in-cell NMR experiments or lysed for protein 
purification. Wild-type ProtL cultures were induced for 1 h in 15N-enriched media 
for in-cell NMR experiments.  
2.2.3   Osmotic Shock 
The location of wild-type ProtL, Kx6Q, Kx6E, and Kx7E in E. coli cells was 
determined by adapting an osmotic shock protocol (57). Cultures producing wild-
type ProtL or Kx7E were induced in the unenriched form of the minimal media 
used for 15N enrichment. Aliquots (1 mL) were collected 0-4 h post induction for 
cultures producing wild-type ProtL or Kx7E. Aliquots (1 mL) were collected 4 h or 
7 h post induction for cultures producing Kx6Q or Kx6E, respectively. The 
cultures were centrifuged in a Centrifuge 5418 benchtop centrifuge (Eppendorf 
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North America; Hauppauge, NY) at 8,000 x g for 10 min. The pellets were 
resuspended in 100 µL of an ice cold 40% (v/v) sucrose, 30 mM Tris-HCl solution 
(pH 7.2) containing 2 mM ethylenediaminetetraacetic acid (EDTA). The 
resuspended pellets were incubated at room temperature for 10 min and then 
centrifuged in the benchtop centrifuge at 10,000 x g for 10-20 min. The pellets 
were resuspended in 90 µL of ice cold water and 10 µL of 20 mM MgCl2. The 
resuspended pellets were incubated on ice for 3 min and then centrifuged in the 
benchtop centrifuge at 12,000 x g for 10-20 min. The supernatants and pellets 
contain periplasmic and cytoplasmic proteins, respectively.  
Protein loading dye, 5x, (300 mM Tris-HCl, pH 6.8, 50% [v/v] glycerol, 
10% [w/v] sodium dodecyl sulfate [SDS], 0.5% [w/v] bromophenol blue [Sigma-
Aldrich Co.]) was added to the the supernatants and pellets (resuspended in 
water) to a final 1x concentration. The samples (20 µL each) were loaded onto 
18% Tris-HCl SDS polyacrylamide gels (Bio-Rad Laboratories, Inc.; Hercules, 
CA) and electrophoresed at 200 V for 50-60 min. The gels were stained with 
Brilliant Blue R-250 (Thermo Fisher Scientific, Inc.; Pittsburgh, PA) and destained 
in aqueous solutions containing 40% (v/v) methanol and 10% (v/v) acetic acid 
followed by final destaining in a 10% methanol, 10% acetic acid solution. Gel 
images were acquired with a VersaDoc 4000 MP Imaging System (Bio-Rad 
Laboratories, Inc.).  
2.2.4   ProtL Purification 
Induced cultures producing wild-type ProtL, Kx6Q, Kx6E, or Kx7E were 
centrifuged in a Sorvall RC-3B centrifuge with a Sorvall H6000A rotor (Thermo 
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Fisher Scientific, Inc.; Waltham, MA) at 4,000 rpm for 30 min at 4 ° C.  The pellets 
were resuspended in 30 mL of 2 M NaCl, 20 mM phosphate buffer (20 mM 
sodium phosphate, pH 6.0) containing 1 mM phenylmethanesulphonylfluoride 
(PMSF). The cell slurries were sonicated on ice with a Sonic Dismembrator 500 
(Thermo Fisher Scientific, Inc.; Pittsburgh, PA) at a 14% amplitude and a 2 s on, 
2 s off duty cycle for a total of 10 min. The lysates were centrifuged in the Sorvall 
RC-5B centrifuge with a Sorvall SS-34 rotor (Thermo Fisher Scientific, Inc.; 
Waltham, MA) at 14,000 rpm for 30 min at 4 ° C. Lysa tes containing Kx7E were 
heated at 100 ° C for 10 min followed by centrifugat ion in the Sorvall RC-5B 
centrifuge with the Sorvall SS-34 rotor at 14,000 rpm for 30 min at 4 ° C. The 
resultant supernatants were concentrated to 5 mL by using a 3,000 molecular 
weight cutoff (MWCO) centrifugal filter unit (EMD Millipore). The lysates were 
loaded onto a Superdex 75 size exclusion column (GE Healthcare; Piscataway, 
NJ), which was equilibrated in and eluted with 2 M NaCl, 20 mM phosphate 
buffer, pH 6.0. Fractions were loaded onto 18% Tris-HCl SDS polyacrylamide 
gels and electrophoresed at 200 V for 50-60 min. The gels were stained, 
destained, and imaged as described in 2.2.3. 
Fractions containing ProtL were pooled and dialyzed against water 
overnight at 4 ° C by using Pierce 3,500 MWCO SnakeSki n Pleated Dialysis 
Tubing (Thermo Fisher Scientific, Inc.; Rockford, IL). The water was exchanged 
twice, and the samples were dialyzed >3 h after each exchange. The proteins 
were lyophilized with a FreeZone 1 Liter Benchtop Freeze Dry System (Labconco 
Corp.; Kansas City, MO) and stored at -80 ° C. 
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2.2.5   NMR 
1H -15N heteronuclear single-quantum coherence (HSQC) spectra were 
acquired at 25 ° C on a Varian Inova 600 MHz spectrome ter (Palo Alto, CA) 
equipped with a triple resonance HCN probe. The 1H dimension sweep width 
was 8401 Hz and comprised 1024 complex points. The 15N dimension sweep 
width was 2200 Hz and comprised 64 complex points. The data were processed 
with NMRPipe (58) and NMRView (59).  
19F spectra were acquired at 37 ° C on the Varian Inova 600 MHz 
spectrometer equipped with a 5 mm 19F {1H} z-gradient probe. The spectra 
comprised 128 to 2048 transients with a 30 kHz sweep width and a 2 s 
acquisition delay. Trifluoroethanol was used as a reference at 0 ppm. 
2.2.6   Dilute Solution NMR NaCl Titrations 
15N-Enriched Kx7E NaCl Titration 
Buffer solutions containing purified 15N-enriched Kx7E in 20 mM 
phosphate buffer with 0 or 1 M NaCl (pH 6.0) were combined to achieve Kx7E 
solutions containing 0 to 1 M NaCl. The Kx7E concentration and pH values were 
the same in all samples. Samples (450 µL each) were pipetted into S500 NMR 
tubes (Norell, Inc.; Landisville, NJ), and HSQC (60) spectra were acquired as 
described in 2.2.5 after adding 10% (v/v) D20.  
A titration curve was produced (Fig. 2.2) by plotting the fraction of folded 
protein versus NaCl concentration (Table 2.1). The data were fit to a two-state 
model of the form 	
   
/!"
#/!"
 where $ is the 
concentration of NaCl, RT is the gas constant times the absolute temperature, 
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 where 
∆° is ∆°- in the absence of NaCl,  and  are the linear folded and unfolded 
baselines defined by   ° . /$ and   ° . 0$, respectively, where ° and ° 
are the intercepts, and / and 0 are the slopes of the folded region and the 
unfolded region, respectively (61).  
19F-Labeled Kx7E NaCl Titration 
A 4 M NaCl, 20 mM phosphate buffer, pH 6.0, solution was added to 
purified 19F-labeled Kx7E in 20 mM phosphate buffer, pH 6.0, in increasing 
amounts to achieve NaCl concentrations of 0.1, 0.2, 0.3, 0.5, and 1 M. 19F 
spectra of 19F-labeled Kx7E were acquired after adding 10% (v/v) D20.  
2.2.7   In Vitro NMR with Synthetic Polymers, Proteins, and Osmolytes 
Purified 19F-labeled Kx7E was dissolved in 20 mM phosphate buffer, pH 
6.0 to a final concentration of 5 mM. Purified 19F-labeled Kx7E was dissolved to a 
final concentration of 2 mM in 20 mM phosphate buffer, pH 6.0, solutions 
containing the following components at final concentrations of 300 g/L: 40-kDa 
polyvinylpyrrolidone (PVP; Sigma-Aldrich Co.), bovine serum albumin (BSA; 
Thermo Fisher Scientific, Inc.; Fair Lawn, NJ), 8-kDa polyethylene glycol (PEG; 
Sigma-Aldrich Co.), 70-kDa Ficoll (Sigma-Aldrich Co.), D-glucose, or dextran 
(Sigma-Aldrich Co.). Purified 19F-labeled Kx7E was dissolved to a final 
concentration of 2 mM in 20 mM phosphate buffer, pH 6.0, solutions containing 
585 g/L sucrose or 72% (v/v) glycerol. Purified 19F-labeled Kx7E was dissolved to 
a final concentration of 3 mM in a 20 mM phosphate buffer, pH 6.0, solution 
containing 600 g/L betaine (Sigma-Aldrich Co.). A final concentration of 10% (v/v) 
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D2O and 1 mM PMSF was added to each sample. The samples were pipetted 
into S500 NMR tubes, and 19F spectra were acquired as described in 2.2.5. 
Glucose solutions at final concentrations of 370, 440, and 610 g/L were prepared 
by successively adding more glucose to the 300 g/L glucose sample after NMR 
acquisitions. Unless otherwise noted, all chemicals are from Thermo Fisher 
Scientific, Inc. (Fair Lawn, NJ).  
2.2.8   In-Cell NMR 
Inducing production in 15N-enriched minimal media for 4 h results in 
leakage of wild-type ProtL as determined by detection of its spectrum in the cell 
supernatant. Reducing the time to 1 h prevented leakage, in agreement with 
previous results (46). Induction in 19F-labeled minimal media does not result in 
leakage because production levels are depressed in this medium.  
E. coli producing wild-type ProtL, Kx6Q, Kx6E, or Kx7E in 15N-enriched 
minimal media, E. coli producing wild-type ProtL or Kx7E in 19F-labeled minimal 
media, E. coli producing Kx7E in hyperosmotic media, and E. coli without an 
expression vector in 15N-enriched minimal media were pelleted by centrifugation 
in the RC-3B centrifuge with the H6000A rotor at 4,000 rpm for 30 min at 25 ° C. 
Pellets of E. coli producing Kx7E in hyperosmotic media were resuspended in 1 
mL of hyperosmotic media per liter of cell culture. All other pellets were 
resuspended in 1 mL of LB media per liter of cell culture. 
D2O was added to the cell slurries to a final concentration of 10% (v/v), 
and the samples were pipetted into S500 NMR tubes. HSQC and 19F spectra 
were acquired as described in 2.2.5. After acquisition, the slurries were removed 
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from the NMR tubes and centrifuged in the benchtop centrifuge at 8,000 x g for 
10 min. Spectra of the supernatants were acquired. The pellets of E. coli induced 
in 15N-enriched minimal media or 19F-labeled media were washed twice with 20 
mM phosphate buffer, pH 6.0, and each pellet was resuspended in 20 mM 
phosphate buffer, pH 6.0, containing PMSF (1 mM final concentration). The cell 
slurries were sonicated on ice with the Sonic Dismembrator 500 at a 14% 
amplitude and a 2 s on, 2 s off duty cycle for a total of 10 min. The lysates were 
centrifuged in the benchtop centrifuge at 17,000 x g for 10 min. A final 
concentration of 10% (v/v) D2O was added to the cleared lysates for HSQC and 
19F NMR acquisition as described in 2.2.5. The 19F spectrum of the Kx7E cell 
lysate was acquired by adding guanidine chloride (3 M final concentration) to the 
insoluble lysate fraction. NaCl or KCl (1 M final concentration) was added to the 
cleared lysates of cells induced in 15N-enriched minimal media, and the HSQC 
spectra were acquired.  
E. coli Producing 19F-Labeled Kx7E in Hyperosmotic Media 
E. coli cultures producing Kx7E were induced with IPTG for 26 h in 
hyperosmotic media (formulation described in 2.2.1). After induction, the cultures 
were prepared for in-cell 19F NMR as described above. Only the in-cell spectrum 
was acquired.   
2.2.9   3-FY 19F ProtL Assignments 
ProtL pET-15b Mutagenesis 
The wild-type ProtL gene from the pET-15b vector was mutated by using a 
site-directed mutagenesis kit (Agilent Technologies, Inc.; Santa Clara, CA) with 
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primers designed to introduce random amino acids at tyrosine positions 34, 36, 
and 56. The primers are shown in Table 2.2. The mutagenesis reactions were 
transformed into XL-1 Blue E. coli cells (Agilent Technologies, Inc.; Santa Clara, 
CA). The cells were plated onto LBAMP plates and incubated for >16 h at 37 ° C. 
Colonies were picked from the plates, inoculated into 5-mL liquid cultures of 
LBAMP, and grown for 12-16 h at 37 ° C with 250-rpm shaki ng. ProtL pET-15b 
plasmid DNA was isolated by using a miniprep kit (Qiagen, Inc.; Valencia, CA) 
and sequenced (University of North Carolina at Chapel Hill [UNC-CH] Genome 
Analysis Facility) to identify constructs with codons encoding amino acids other 
than tyrosine at positions 34, 36, and 56. 
ProtL Variant Production in LB Media 
Positive clones were transformed into BL21(DE3) E. coli cells, streaked 
onto LBAMP plates, and incubated overnight at 37 ° C. Colonies were picked from 
the plates and used to inoculate 5 mL of liquid LBAMP. The cultures were 
incubated at 37 ° C with 250-rpm shaking. IPTG (1 mM final concentration) was 
added when the cultures reached an OD600 of 0.6. The induced cultures were 
incubated for 4 h at 37 ° C with 250-rpm shaking. One -mL aliquots of the cultures 
were centrifuged in the benchtop centrifuge at 8,000 x g for 10 min. The pellets 
were resuspended in 80 µL of water and 20 µL of 5x protein loading dye and 
heated for 10 min at 100 ° C. Cell lysates (15 µL each ) were loaded onto 10-20% 
Tris-HCl SDS polyacrylamide gels (Bio-Rad Laboratories, Inc.) and 
electrophoresed at 200 V for 65 min. The gels were stained, destained, and 
imaged as described in 2.2.3.  
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ProtL Variant Production in Unlabeled Tyrosine Minimal Media 
Colonies were picked from the same plates described above and 
inoculated into 5-mL of liquid LBAMP. The cultures were incubated at 37 ° C with 
250-rpm shaking to an OD600 of 0.6. The cultures were centrifuged at full speed 
in an IEC HN-SII centrifuge (Thermo Fisher Scientific, Inc.; Pittsburgh, PA) for 10 
min at room temperature. The supernatants were decanted and the cell pellets 
resuspended each in 5 mL of unlabeled tyrosine minimal media. The cultures 
were incubated at 37 ° C with 250-rpm shaking. IPTG ( 1 mM final concentration) 
was added when the cultures reached an OD600 of 0.8. The induced cultures 
were incubated for 20-24 h at 37 ° C with 250-rpm sha king. Cells were 
harvested, lysed, and visualized for protein production as described above. 
ProtL Variant Production in 19F-Labeled Minimal Media for 19F NMR Assignments 
Colonies of BL21(DE3) E. coli cells producing the ProtL Y34A, Y36H, or 
Y56N variants were picked from LBAMP plates and used to inoculate 100 mL of 
liquid LBAMP. The cultures were incubated overnight at 37 ° C wit h 250-rpm 
shaking. Each culture (25 mL) was centrifuged at full speed in the IEC HN-SII 
centrifuge for 10 min at room temperature to pellet the cells. Each pellet was 
resuspended in 250 mL of 19F-labeled minimal media. The cultures were 
incubated at 37 ° C with 250-rpm shaking. IPTG (1 mM final concentration) was 
added when the cultures reached an OD600 of 0.8. The induced cultures were 
incubated for 24 h at 37 ° C with 250-rpm shaking. The  cells were pelleted by 
centrifugation in the RC-3B centrifuge with the H6000A rotor at 4,000 rpm for 10 
min at 25 ° C. The supernatants were decanted, and t he pellets were washed 
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twice with LB media. Each pellet was resuspended in 250 mL of LB media 
containing PMSF (1 mM final concentration). The cell slurries were sonicated on 
ice with the Sonic Dismembrator 500 at a 14% amplitude and a 2 s on, 2 s off 
duty cycle for a total of 10 min. The lysates were centrifuged in the benchtop 
centrifuge at 17,000 x g for 10 min. A final concentration of 10% (v/v) D2O was 
added to the cleared lysates. The cleared lysates were pipetted into S500 NMR 
tubes, and 19F spectra were acquired as described in 2.2.5.  
Assignment Rationale and Results 
Unfortunately, there is no current way to relate the chemical shifts from 
fluorine-containing amino acids to the protein environment as acquired by X-ray 
crystallography or NMR spectroscopy. Therefore, assignments are achieved by 
using site directed mutagenesis (62). Wild-type ProtL contains tyrosines at 
positions 34, 36, and 56. Creating three variants of the protein, where the 
tyrosine residue at each position is substituted for a different amino acid, allows 
assignment of the 19F resonances. Each variant gives rise to a 19F spectrum with 
just two resonances from the protein. 
When making mutations, common sense suggests that the amino acid 
size and net charge should be perturbed as little as possible so that the protein 
structure is not significantly altered. Thus, mutagenesis was performed on the 
pET-15b vector to mutate the codons encoding the three tyrosines in wild-type 
ProtL to encode phenylalanines, which are similar in size and have the same net 
neutral charge. BL21 E. coli cells producing these variants, however, were 
unable to grow in 19F-labeled minimal media. Inexplicitly, the variant caused the 
20 
 
apparent cellular toxicity because BL21 E. coli cells producing wild-type ProtL 
have no difficulty growing in 19F-labeled minimal media.  
A second strategy was developed to perform the assignments where no 
bias in the amino acid substitution was introduced. Primers were designed (Table 
2.2) with random nucleotide substitutions at the codons encoding the wild-type 
ProtL tyrosines at positions 34, 36, and 56. By using these random primers, 
multiple pET-15b mutants are generated. Transformation of these vectors into E. 
coli allows screening for the cultures that can grow in 19F-labeled minimal media 
and produce the variants. Additionally, a basic local alignment search tool 
(BLAST) was used to find naturally occurring ProtL variants at postions 34, 36, or 
56. The rationale is that naturally occurring ProtL variants are less likely to be 
toxic to E. coli than genetically modified variants utilizing random amino acid 
substitutions. The BLAST search yielded a ProtL variant from the bacterium 
Finegoldia magna where tyrosine 56 is changed to asparagine (63). Therefore, 
primers were also designed to mutate the codon encoding amino acid position 56 
to asparagine (Table 2.2). DNA sequencing confirmed the generation of pET-15b 
mutants encoding the ProtL variants Y34A, Y34P, Y34L, Y36P, Y36H, Y36Q, 
Y56Q, Y56S, Y56V, and Y56N. Results from SDS-PAGE (Fig. 2.3 and Fig. 2.4) 
show overproduction of the ProtL variants, with the exception of the Y34P 
variant. The production levels of the variants are similar in LB media and 
unlabeled tyrosine minimal media (Fig. 2.3 and Fig. 2.4) and in 19F-labeled 
minimal media (Fig. 2.3b). Importantly, the production levels of the variants in all 
tested media are comparable to the production level of wild-type ProtL in LB 
21 
 
media. The 19F lysate spectrum is easily acquired for E. coli producing wild-type 
ProtL (Fig. 2.5e) Thus, any of these ProtL variants, excluding the Y34P variant, 
should provide suitable production levels in 19F-labeled minimal media. 
The 19F spectra of the cell lysates producing the Y34A, Y36H, or Y56N 
variants in 19F-labeled minimal media (Fig. 2.5b-d) each display two protein 
resonances and one resonance from unincorporated 3-FY. Taken together, the 
spectra allow assignment of the three tyrosines in wild-type ProtL (Fig. 2.5a). 
Interestingly, while the protein resonances from the Y56N variant are strong and 
comparable to those from the wild-type ProtL cell lysate spectrum (Fig. 2.5e), the 
protein resonances from the Y34A and Y36H variants are weaker (Fig. 2.5b, c). 
The production levels of these two variants in 19F-labeled minimal media (Fig. 
2.3b) are the same as the wild-type protein in LB media (Fig. 2.3a). The 
reduction in signal for the Y34A and Y36H variants might be caused by 
aggregation or by binding of the recombinant proteins to cellular components. 
This hypothesis, while not tested here, could be examined by adding denaturants 
such as guanidine chloride to the samples and checking for recovery of strong 
protein resonances in the 19F spectra. 
2.3   Results 
2.3.1  Wild-type ProtL, Kx6Q, Kx6E, and Kx7E are Located in the Cytoplasm 
Detection of wild-type ProtL and its variants in the cytoplasm or periplasm 
of E. coli was performed by osmotically shocking E. coli cells to separate the 
cytoplasm and periplasm (57). SDS polyacrylamide gel electrophoresis (SDS-
PAGE) results (Fig. 2.6) show an increase in the production of wild-type ProtL 
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and the Kx7E variant over 4 h of induction in minimal media. Kx7E is located 
almost entirely in the cytoplasm through 4 h. The wild-type protein is primarily 
located in the cytoplasm from 0 to 1 h. Later, it is present in similar quantities in 
both compartments. At all time points the production level of the wild-type protein 
is greater than that of Kx7E. These observations are consistent with the idea that 
increasing production causes cytoplasmic proteins to migrate to the periplasm 
(46). For all studies of the wild-type protein, the production time was limited such 
that the protein is in the cytoplasm. 
SDS-PAGE results (Fig. 2.7) show that Kx6Q and Kx6E are located 
primarily in the cytoplasm after 4 h and 7 h of induction in minimal media, 
respectively. Kx6E is also present in the periplasmic fraction, possibly because 
the culture was induced for 7 h rather than 4 h. The production level of these two 
variants appears higher than that of Kx7E, most likely due to the introduction of 
one fewer mutation.   
2.3.2   Wild-Type ProtL is Folded in Dilute Solution 
The fold was monitored by using the 1H-15N HSQC experiment. The 
spectrum shows that the protein is folded (Fig. 2.8a) as indicated by the large 
dispersion of 1H chemical shifts. The fold was also assessed by using 19F NMR. 
Wild-type ProtL contains three tyrosines, so the substitution of 3-FY for tyrosine 
(64) is expected to yield three resonances in the 19F spectrum. This prediction is 
borne out (Fig. 2.9a). The resonances are well separated as expected for a 
folded protein. 
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2.3.3   Kx7E Requires Salt to Fold in Dilute Solution 
Purified, 15N-enriched Kx7E was dissolved in 20 mM phosphate buffer 
solutions, pH 6.0, containing 0 to 1 M NaCl. The limited 1H chemical shift 
dispersion observed in the HSQC spectrum (Fig. 2.8b) indicates that the variant 
is unfolded in buffer alone (55, 65-67). Upon increasing the NaCl concentration to 
0.3 M, the dispersion increases to that expected for a folded protein, although 
crosspeaks from the unfolded form are also visible (Fig. 2.8c). In 0.8 M NaCl, 
almost all of the variant is folded (Fig. 2.8d) and the crosspeak pattern is similar 
to that of the wild-type protein (Fig. 2.8a).  
HSQC spectra were acquired from 0 to 1 M NaCl in 0.1 M intervals (Fig. 
2.10), and the average intensities of the unfolded and folded Kx7E crosspeaks at 
each NaCl concentration (Table 2.1) were used to produce a titration curve (Fig. 
2.2). The results show that the transition is 50% complete at 0.3 M NaCl and 
reaches a maximum at 0.8 M NaCl. Even at 0.8 M NaCl, a few crosspeaks from 
the unfolded protein remain (Fig. 2.10i). The data were fit to a two-state model 
that assumes linear native and denatured state baselines and a linear 
dependence of the standard unfolding free energy on salt concentration (61). The 
standard unfolding free energy at 0 M NaCl, ∆°, is -1.0 kcal/mol (RMSD of 
2%). This value represents the free energy required to fold half the variant 
molecules in the absence of NaCl. The salt-induced folding is reversible (55). 
The fold of the Kx7E variant was then monitored by using 19F NMR. 
Purified 19F-labeled Kx7E was dissolved in 20 mM phosphate buffer solutions, pH 
6.0, containing NaCl at concentrations from 0 to 1 M. The spectrum acquired at 
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37 ° C in the absence of added NaCl (Fig. 2.9 b) shows the three expected 
resonances in a narrow chemical shift range, indicative of an unfolded protein. As 
the NaCl concentration increases, the Y34 and Y36 resonances from the folded 
protein appear downfield, and the intensities of the resonances attributed to the 
unfolded protein decrease (Fig. 2.9c-f). At 1 M NaCl (Fig. 2.9g), most of the Kx7E 
variant is folded, although unfolded protein resonances remain at low intensities. 
The chemical shifts from the variant in 1 M NaCl are consistent with those of 
wild-type ProtL (Fig. 2.9a). The increasing fraction of folded protein with 
increasing NaCl concentration is consistent with the HSQC data (Fig. 2.10), 
although not enough data points were acquired for quantification.  
2.3.4   Kx7E Does Not Fold Under In Vitro Crowded Conditions 
The ability of synthetic polymers and proteins to fold the Kx7E variant was 
monitored by using 19F NMR. Purified and lyophilized 19F-labeled Kx7E was 
resuspended in 20 mM phosphate buffer, pH 6.0, solutions containing 300-g/L 
final concentrations of PEG, PVP, Ficoll, or BSA. The 19F spectra in the synthetic 
polymers and BSA (Fig. 2.11b-e) remain unchanged with respect to Kx7E in 
buffer alone (Fig. 2.11a). The BSA sample displays some broadening (Fig. 
2.11e), suggesting that the crowder chemically interacts with Kx7E (48). The 
results show that these macromolecular crowders are unable to fold Kx7E.  
High concentrations of several sugars and osmolytes were also tested. 
The 19F spectra of Kx7E in 72% (v/v) glycerol and 300 g/L dextran (Fig. 2.12b, c) 
are unchanged from that of the variant in buffer (Fig. 2.11a). The 19F spectra of 
Kx7E in 585 g/L sucrose and 600 g/L betaine (Fig. 2.12a, d) show a single 
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downfield resonance that may be from the folded protein. The 19F spectrum of 
Kx7E in 300 g/L glucose (Fig. 2.13), however, shows the downfield Y34 and Y36 
resonances from the folded protein. The sample was removed from the NMR 
tube so that additional glucose could be added to acquire 19F spectra at glucose 
concentrations of 370, 440, and 610 g/L (Fig. 2.13). Each successively higher 
glucose concentration causes an increase in the intensity of the Y34 and Y36 
resonances from the folded protein and a corresponding decrease in the 
unfolded protein resonances. Glucose remains the only tested candidate, other 
than NaCl, to fold Kx7E. Next, in-cell NMR was used to determine whether the 
crowded conditions in the E. coli cytoplasm could fold the protein. 
2.3.5   Wild-Type ProtL is Folded in E. coli 
In-cell NMR was used to assess wild-type ProtL in E. coli. The HSQC 
spectrum of the cell slurry containing the 15N-enriched wild-type protein is shown 
in Fig. 2.14a. The spectrum is the same as that of cells without an expression 
vector (Fig. 2.15); the spectrum of the protein is unobservable. The only 
crosspeaks in Fig. 2.14a are from 15N-enriched metabolites (68). These 
observations are consistent with results showing that 1H-15N HSQC spectra from 
globular proteins are not detectable in E. coli (49, 52, 69, 70). After lysing the 
cells, the wild-type ProtL spectrum is detected (Fig. 2.14c) and is unchanged in 
the presence of 1 M NaCl (Fig. 2.14d). The spectrum of the cell supernatant 
shows no protein crosspeaks (Fig. 2.14b), confirming that the protein is in the 
cells. To detect wild-type ProtL in cells, 19F NMR was utilized (70). 
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The in-cell experiments were repeated with 19F-labeled wild-type ProtL. 
The high sensitivity of 19F, the more favorable relaxation properties of 19F in a 
mobile side chain, the low background of fluorine in biological molecules, and the 
limited number of labels per protein allow detection of globular proteins in E. coli 
(52). Three broad resonances from the protein corresponding to Y34, Y36, and 
Y56 (Fig. 2.5) were detected in the 19F spectrum of the cell slurry (Fig. 2.16a). 
The fourth resonance, from unincorporated 3-FY, is sharper and overlaps the 
Y56 resonance. The protein resonances are well separated and similar to those 
from the in vitro spectrum of wild-type ProtL (Fig. 2.9a), indicating that the wild-
type protein is folded in the cytoplasm of E. coli. The spectrum of the supernatant 
also shows a sharp resonance from unincorporated 3-FY (Fig. 2.16b). Three 
additional small resonances are detected. The positions of these resonances 
match those of wild-type ProtL in dilute solution (Fig. 2.9a), suggesting that a 
small amount of protein (less than 10%) leaks from the cells, but not enough to 
obscure the spectrum of the cell slurry. The cleared cell lysate (Fig. 2.16c) shows 
three sharp resonances corresponding to Y34, Y36, and Y56 from the protein, 
proving that the spectrum of the cell slurry (Fig. 2.16a) is from wild-type ProtL 
inside cells. These data demonstrate that wild-type ProtL remains folded in E. 
coli and can be detected by 19F NMR.  
2.3.6   Kx7E is Unfolded in E. coli  
Disordered proteins are detectable in cells by HSQC NMR because of 
their internal motion (49, 52, 69). The HSQC spectrum of the Kx7E cell slurry 
exhibits a narrow chemical shift dispersion in the 1H dimension (Fig. 2.14e), 
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characteristic of the unfolded protein (Fig. 2.8b). The ability to detect the HSQC 
spectrum of the variant in cells also shows that the protein is soluble in the E. coli 
cytoplasm. The spectrum of the cell supernatant shows no protein crosspeaks 
(Fig. 2.14f), indicating that the spectrum shown in Fig. 2.14e arises from the 
variant inside cells. The variant remains unfolded upon cell lysis (Fig. 2.14g) but 
folds upon increasing the NaCl (Fig. 2.14h) or KCl (Fig. 2.17b) concentration to 1 
M. These results demonstrate that, although Kx7E is foldable, the E. coli 
cytoplasm is unable to fold the variant.  
The HSQC results were confirmed by using 19F NMR. The 19F spectrum of 
the Kx7E cell slurry displays an envelope of broad resonances in a narrow 
chemical shift range and a sharp peak attributed to unincorporated 3-FY (Fig. 
2.16d). The position of the broad envelope is inconsistent with the resonances 
from the folded wild-type protein (Fig. 2.9a and Fig. 2.16a) but consistent with the 
position of the resonances from the purified unfolded Kx7E variant (Fig. 2.9b). 
The absence of the downfield Y34 resonance from the folded variant (Fig. 2.9g) 
is especially evident. No resonances from the Kx7E variant are detected in the 
spectrum of the supernatant, indicating that the protein does not leak (Fig. 
2.16e). Almost no protein signal is detected in the spectrum of the cleared lysate 
(Fig. 2.18a). To gain insight, the pellet retained from cell lysis was resuspended 
and used to acquire a 19F spectrum. Broad resonances, most likely from Kx7E, 
were detected (Fig. 2.18b). Sharp resonances, however, were recovered after 
adding guanidine chloride (Fig. 2.16f). The spectrum of Kx7E cannot be 
observed in the cleared lysate because the protein binds the insoluble fraction. 
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These results corroborate the in-cell HSQC spectra, demonstrating that Kx7E 
remains unfolded in cells.  
2.3.7   Kx6Q and Kx6E NMR Results in E. coli  
 In addition, the folds of the Kx6Q and Kx6E variants were assessed in E. 
coli by using HSQC NMR. The unfolding free energies for the Kx6Q and Kx6E 
variants are 4.00-4.15 and 0.50-0.60 kcal/mol, respectively, in dilute solution as 
determined by guanidine chloride and urea titration experiments with circular 
dichroism detection (55). Therefore, both variants are stable globular proteins. 
Both cell slurry spectra (Fig. 2.19a, e) resemble the spectrum of intracellular 
metabolites (Fig. 2.15). No crosspeaks from Kx6Q or Kx6E were detected in the 
spectra of the supernatants (Fig. 2.19b, f). Upon lysis, the Kx6Q spectrum is 
detected and is characteristic of a folded protein (Fig. 2.19g). No protein is 
detected in the Kx6E cell lysate spectrum (Fig. 2.19c), suggesting aggregation or 
lack of Kx6E production in E. coli. Adding 1 M NaCl has no effect on either 
spectrum (Fig. 2.19d, h), which is expected for the stable globular protein Kx6Q 
and in the absence of soluble Kx6E. To check the reproducibility of the Kx6E 
result, another in-cell NMR experiment was performed with E. coli producing 
Kx6E. The spectrum of the cell slurry resembles the spectrum of intracellular 
metabolites (Fig. 2.20a), but also contains broad crosspeaks that are widely 
dispersed along the 1H dimension. Recovery of protein crosspeaks in the 
spectrum upon cell lysis confirms the presence of Kx6E (Fig. 2.20b), and the 
wide chemical shift dispersion along the 1H dimension indicates that Kx6E is 
folded as expected for a stable globular protein.  
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2.3.8   Increasing the Salt Concentration in Cells Fails to Fold Kx7E 
An attempt was made to fold the Kx7E variant in E. coli by increasing the 
intracellular concentration of K+ by growth and induction of E. coli in 
hyperosmotic (1.05 Osm) media (56, 71, 72). The 19F spectrum of the Kx7E cell 
slurry in hyperosmotic media (Fig. 2.16g), however, shows no resonances from 
the folded protein. The increase in linewidth and the upfield shift of the resonance 
envelope of the unfolded protein is probably caused by the intracellular increase 
in K+ concentration. 
2.4   Discussion 
Many in vitro studies of macromolecular crowding focus on volume 
exclusion. In these experiments, the environment comprises only one or a few 
different types of crowders. Furthermore, it is usually assumed that the crowding 
molecules have little interaction with the test protein unless their van der Waals 
surfaces attempt to overlap, at which point the repulsive forces increase in a 
highly exponential manner. Recent work, however, demonstrates the importance 
of non-specific intermolecular interactions in both experiments and simulations 
(32, 48, 73, 74). Thus, one cannot ignore the effects of chemical interactions in 
studies of macromolecular crowding.  
The unstable Kx7E variant of the globular protein L was examined. The 
variant folds in the presence of high concentrations of salt (55), prompting the 
question whether the excluded volume provided by the E. coli cytoplasm would 
have a similar effect.  
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In vitro HSQC spectra of the variant were acquired in increasing 
concentrations of NaCl. The spectra allowed construction of a folding titration 
curve. The standard unfolding free energy of Kx7E in the absence of NaCl, ∆°, 
is -1.0 kcal/mol. This NMR derived value compares favorably to those derived by 
Tadeo et al. (-0.4 to -0.5 kcal/mol) from guanidine chloride and urea titration 
experiments with circular dichroism detection (55). Therefore, the E. coli 
cytoplasm would have to deliver between 0.4 and 1.0 kcal/mol of stabilization to 
fold 50% of the protein molecules.  
Attempts to fold Kx7E in vitro were made by addition of synthetic 
polymers, proteins, sugars, and osmolytes at high concentrations (≥300 g/L). 
None of the tested crowders, with the exception of glucose, were able to fold the 
variant. The volume exclusion provided by these crowders may not be able to 
fold Kx7E into the thermodynamically favored native globular state because the 
crowders bind weakly to Kx7E (48, 74, 75). The ability of the small molecule 
glucose to fold the variant points to an effect other than macromolecular 
crowding induced volume exclusion.  
In-cell NMR data (Fig. 2.14 and Fig. 2.16) show that wild-type ProtL is 
folded in E. coli while the Kx7E variant remains unfolded. The E. coli cytoplasm 
does not provide sufficient free energy to fold Kx7E. More specifically, the 
volume exclusion provided by the highly crowded intracellular environment, 
which always favors the native state of globular proteins, is insufficient to 
overcome the unfavorable free energy of folding (-1.0 kcal/mol). Predictions from 
theory show that volume exclusion could provide 2.5 kcal/mol of stabilization for 
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a protein the size of ProtL (76). The fact that Kx7E is unfolded in the E. coli 
cytoplasm suggests the presence of a destabilizing effect.  
Experiments were conducted to test whether increasing the K+ 
concentration in cells could fold the Kx7E variant. Although NaCl was used in the 
in vitro experiments (Figs. 2.9-2.11), addition of 1 M KCl to E. coli lysates 
producing Kx7E demonstrates that KCl also folds the variant (Fig. 2.17b). The 
cytoplasmic K+ concentration in E. coli is ~0.2 M (71, 72) for cells grown in 
minimal media (0.1 Osm). Nearly all of the cytoplasmic K+ in E. coli grown in 
minimal media, however, is associated with polyanions such as DNA and RNA 
(56). Thus, not enough salt is available to fold the variant in E. coli.   
The cytoplasmic concentration of K+ was increased by increasing the 
osmolality of the growth medium from 0.16 Osm to 1.05 Osm with NaCl. The E. 
coli cell membrane is impermeable to NaCl, so the cells compensate for the 
increased external osmolality by increasing the amounts of K+, glutamate-, 
trehalose, proline, and glycine betaine in the cytoplasm (72). Under these 
conditions the cytoplasmic K+ concentration reaches between 0.5 and 0.9 M (71, 
72). Importantly, at least half of this upshift in K+ is due to an increase in free 
cytoplasmic K+ rather than K+ that is locally accumulated with polyanions (71). 
Therefore, the concentration of free cytoplasmic K+ under hyperosmotic 
conditions is at least 0.3 M, which leads to easily detectable levels of the folded 
protein in vitro (Fig. 2.2 and Fig. 2.9). Even under these conditions the folded 
form is not detected in cells (Fig. 2.16g). Furthermore, it is unlikely that the 
unfolded form is associated with chaperones because the observation of 
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crosspeaks in Fig. 2.14e is inconsistent with the molecular weight of a Kx7E-
chaperone or proteasome complex (77).  
Our results suggest that any stabilizing excluded volume effect, which 
must exist because of the high concentration of macromolecules in the 
cytoplasm, is more than offset by a destabilizing effect. The destabilization 
probably arises from non-specific protein-protein interactions. Wang et al. show 
that rotational diffusion of the globular protein chymotrypsin inhibitor 2 is slowed 
beyond that expected by viscosity alone in crowded protein solutions and E. coli 
lysates, and that the difference is due to non-specific interactions between the 
crowders and test protein (48). These non-specific intermolecular interactions in 
cells can lead to irreversible denaturation (78), explaining why the Kx7E variant is 
unfolded in cells. Such non-specific protein-protein interactions also explain why 
the variant does not fold completely in vitro even at high salt concentrations (Fig. 
2.2, Fig. 2.8d, and Fig. 2.9g).  
Although volume exclusion is expected to stabilize the native state of 
globular proteins, it must be borne in mind that the E. coli cytoplasm comprises 
biologically active molecules. These molecules chemically interact with the 
protein under study, and these interactions can be stabilizing or destabilizing. 
Therefore, it is not clear, a priori, how macromolecular crowding in cells, which 
includes both volume exclusion and chemical interactions, will affect protein 
stability (29). The few available in-cell studies of globular protein stability indicate 
no change or a slight destabilization in cells compared to dilute solution (15, 16). 
Although dilute solution data may be physiologically relevant for stable globular 
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proteins, the data presented here show that non-specific intermolecular 
interactions can overcome volume exclusion induced compaction, causing 
globular proteins to remain unfolded. The situation is different for intrinsically 
disordered proteins where the crowded environment in cells results in 
compaction (17). The dissimilar behavior is probably caused by the different 
amino acid compositions of these two protein classes (79). 
Given that salt folds the variant in vitro, it is striking that increasing the 
intracellular salt concentration fails to have the same effect. This discrepancy 
indicates that non-specific intermolecular interactions may prevent refolding of 
globular proteins even when solution conditions favor it, leading to the suggestion 
that the rate of unfolding in cells deserves attention.  
2.5   Conclusions  
 Wild-type ProtL and the Kx6Q, Kx6E, and Kx7E variants were purified 
from E. coli for use in in vitro and in-cell NMR experiments. Conditions were 
found such that all the proteins were located in the cytoplasm of E. coli after 
induction.  
In vitro HSQC and 19F NMR experiments show that Kx7E is unfolded in 
the absence of NaCl, 50% folded at 0.3 M NaCl, and reaches the maximum 
folded fraction at 0.8 M NaCl (90%). The standard unfolding free energy of Kx7E 
in the absence of NaCl, ∆°, is -1.0 kcal/mol. The cell must provide this amount 
of free energy to fold half the variant molecules. NMR spectra show that wild-type 
ProtL is folded in the absence of NaCl.  
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In-cell HSQC and 19F NMR results are consistent with wild-type ProtL 
remaining folded in E. coli. In-cell HSQC and 19F NMR results show that Kx7E is 
unfolded in E. coli. Therefore, the E. coli cytoplasm does not provide sufficient 
free energy (-1.0 kcal/mol) to fold Kx7E. The data support the conclusion that the 
volume exclusion provided by macromolecular crowding is unable to overcome 
the non-specific intermolecular interactions in E. coli, thus maintaining Kx7E in its 
unfolded form.  
An attempt was made to fold Kx7E by increasing the intracellular 
concentration of K+ in E. coli. E. coli producing Kx7E were grown in hyperosmotic 
media to increase the free cytoplasmic K+ to at least 0.3 M, which in dilute 
solution leads to easily detectable levels of the folded protein. The spectrum of 
the cell slurry, however, shows a spectrum similar to that obtained in normal 
osmolality media, indicating that Kx7E remains unfolded. Thus, macromolecular 
crowding and increased K+ concentrations are unable to overcome the non-
specific intermolecular interactions present in the E. coli cytoplasm. 
These results emphasize the importance of examining non-specific 
intermolecular interactions in cells. While the concentration of macromolecules in 
the E. coli cytoplasm can exceed 300 g/L, providing significant volume exclusion 
expected to favor the native state of globular proteins, these biological molecules 
are not inert. They include proteins, nucleic acids, osmolytes, and other 
molecules, and they chemically interact with the protein under study. These 
interactions can be stabilizing or destabilizing, making predictions of protein 
stability in cells difficult. The inability of the E. coli cytoplasm to fold Kx7E 
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suggests the presence of destabilizing non-specific intermolecular interactions 
that volume exclusion is unable to overcome. The fact that even increasing the 
free cytoplasmic K+ to at least 0.3 M fails to fold Kx7E supports the idea that 
these non-specific intermolecular interactions prevent refolding even though the 
solution conditions favor it. Therefore, the study of protein unfolding rates in cells 
provides an interesting avenue for further investigation. 
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2.6   List of Tables 
 
Table 2.1 Kx7E dilute solution NaCl titration   
 
NaCl (M) 
Number of 
Unfolded 
Crosspeaks 
Number of 
Folded 
Crosspeaks 
Ratio of Average 
Folded/Unfolded 
Volumes 
Fraction 
Folded 
 
0.00 67 0 0.00 0 
0.10 55 53 0.12 0.10 
0.15 54 63 0.20 0.19 
0.20 57 68 0.41 0.33 
0.25 57 69 0.53 0.39 
0.30 58 66 0.88 0.50 
0.40 56 67 1.36 0.62 
0.50 39 105 0.98 0.73 
0.60 19 107 0.99 0.85 
0.70 22 106 1.26 0.86 
0.80 7 97 0.65 0.90 
 
Crosspeaks attributed to the folded and unfolded forms were counted in each 
HSQC spectrum. Backbone amide crosspeaks present in the 0 M NaCl spectrum 
were attributed to the unfolded protein. Crosspeaks that appeared upon adding 
NaCl were attributed to the folded protein. For each spectrum, the average 
volume of the crosspeaks attributed to the folded protein was divided by the 
average volume of the crosspeaks attributed to the unfolded protein. The fraction 
of the folded protein at each concentration was calculated by using the following 
equation: 
Fraction Folded 
Number@ABCDC E Avg. Volume@ABCDC
Number@ABCDC E Avg.  Volume@ABCDC . NumberKL@ABCDC E Avg.  VolumeKL@ABCDC
 
 
 
Table 2.2 ProtL pET-15b mixed primers used to introduce random amino acids at 
positions 34, 36, and 56 in wild-type ProtL  
 
         Name                                        Sequence 
 
Forward Y34Any 5' GCAACTAGTGAAGCTNNNGCATATGCAGATACTTTGAAGAAAGAC 3' 
Reverse Y34Any 5' GTCTTTCTTCAAAGTATCTGCATATGCNNNAGCTTCACTAGTTGC 3' 
Forward Y36Any 5' GCAACTAGTGAAGCTTATGCANNNGCAGATACTTTGAAGAAAGAC 3' 
Reverse Y36Any 5' GTCTTTCTTCAAAGTATCTGCNNNTGCATAAGCTTCACTAGTTGC 3' 
Forward Y56Any 5' GTCGACGTTGCAGATAAAGGTNNNACTTTAAATATTAAATTTGCTGG 3' 
Reverse Y56Any 5' CCAGCAAATTTAATATTTAAAGTNNNACCTTTATCTGCAACGTCGAC 3' 
Forward Y56N 5' GTCGACGTTGCAGATAAAGGTAACACTTTAAATATTAAATTTGCTGG 3' 
Reverse Y56N 5' CCAGCAAATTTAATATTTAAAGTGTTACCTTTATCTGCAACGTCGAC 3' 
 
The altered codons are underlined 
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Figure 2.1 pET-15b vector map.   
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Figure 2.2 Titration curve showing the fraction of folded Kx7E (20 mM phosphate 
buffer, pH 6.0, 25 ° C) as a function of NaCl concentr ation. The data were fit to a 
two-state model (61).  
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Figure 2.3 E. coli lysates producing ProtL Y34 and Y36 variants visualized by 
Brilliant Blue SDS-PAGE. a) Lysates of cells grown and induced in LB media and 
unlabeled tyrosine minimal media. Lanes 5-10 contain lysates of cells grown and 
induced in LB media to produce the variants Y34P (lane 5), Y34A (lane 6), Y34L 
(lane 7), Y36P (lane 8), Y36H (lane 9), and Y36Q (lane 10). Lanes 11-16 contain 
lysates of cells grown and induced in unlabeled tyrosine minimal media to 
produce the variants Y34P (lane 11), Y34A (lane 12), Y34L (lane 13), Y36P (lane 
14), Y36H (lane 15), and Y36Q (lane 16). Lane 1 contains a protein molecular 
weight marker. Lanes 2 and 3 contain lysates of cells producing the wild-type 
ProtL and the Kx7E variant in LB media, respectively. Lane 4 contains the lysate 
of cells producing the Y56N variant in LB media. b) Lysates of cells grown and 
induced in 19F-labeled minimal media to produce the variants Y34A (lane 1) and 
Y36H (lane 2).   
 
 
 
 
 
 
ProtL 
kDa 
10 
15 
25 
35 
50 
70 
100 
140 
 8   9   1   2   3   4   5   6   7  
 
10  
 
11  
 
12  
 
13  
 
14  
 
15  
 
16  a) b) 1   2  
40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 E. coli lysates producing ProtL Y56 variants visualized by Brilliant 
Blue SDS-PAGE. a) Lysates of cells grown and induced in LB media. Lane 1 
contains a protein molecular weight marker followed by the variants Y56N (lanes 
2-3), Y56Q (lane 4), Y56S (lane 5), and Y56V (lanes 6-7). b) Lysates of cells 
grown and induced in unlabeled tyrosine minimal media. Lane 1 contains a 
protein ladder followed by the variants Y56N (lanes 4-9), Y56Q (lanes 10-11, 
Y56S (lanes 12-13), and Y56V (lanes 14-17). Lanes 2 and 3 contain lysates of 
cells producing wild-type ProtL and the Kx7E variant in LB media, respectively.  
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Figure 2.5 19F assignment spectra (37 ° C) of ProtL. a) Purified wild- type ProtL 
(20 mM phosphate buffer, pH 6.0, 37 ° C). Lysates of E. coli cells producing the 
variants b) Y34A, c) Y36H, and d) Y56N. e) Lysate of E. coli cells producing wild-
type ProtL. Asterisks denote the resonance from free 3-FY. 
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Figure 2.6 ProtL location determined by osmotic shock. Brilliant Blue SDS-PAGE 
results of periplasmic and cytoplasmic fractions of E. coli producing a) the Kx7E 
variant and b) the wild-type protein. Cells were harvested and lysed 0-4 h after 
induction in minimal media. Lanes 1, 3, 5, 7, and 9 correspond to the periplasm. 
Lanes 2, 4, 6, 8, and 10 correspond to the cytoplasm. Lanes 1-2, 3-4, 5-6, 7-8, 
and 9-10 correspond to induction times of 0 h, 0.5 h, 1 h, 2 h, and 4 h, 
respectively.   
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Figure 2.7 Brilliant Blue SDS-PAGE results of periplasmic and cytoplasmic 
fractions of osmotically shocked E. coli cells producing Kx6Q and Kx6E in 
minimal media. Lanes 1 and 2 contain Kx6Q and Kx6E whole cell lysates, 
respectively. Lanes 3 and 4 contain periplasmic and cytoplasmic fractions of 
Kx6Q, and lanes 5 and 6 contain periplasmic and cytoplasmic fractions of Kx6E, 
respectively. E. coli Kx6Q induction time was 4 h while E. coli Kx6E induction 
time was 7 h. 
Q: ProtL Kx6Q 
E: ProtL Kx6E 
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Figure 2.8 HSQC spectra (20 mM phosphate buffer, pH 6.0, 25 ° C) of 15N-
enriched a) wild-type ProtL and 15N-enriched Kx7E in b) 0 M, c) 0.3 M, and d) 0.8 
M NaCl.  
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Figure 2.9 19F spectra (20 mM phosphate buffer, pH 6.0, 37 ° C) of  19F-labeled 
a) wild-type ProtL and 19F-labeled Kx7E in b) 0 M, c) 0.1 M, d) 0.2 M, e) 0.3 M, f) 
0.5 M, and g) 1 M NaCl. Assignments were made by using mutagenesis (Table 
2.2 and Fig. 2.5). 
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Figure 2.10 HSQC spectra (20 mM phosphate buffer, pH 6.0, 25 ° C ) of 15N-
enriched Kx7E in a) 0 M, b) 0.1 M, c) 0.2 M, d) 0.3 M, e) 0.4 M, f) 0.5 M, g) 0.6 M, 
h) 0.7 M, i) 0.8 M, and j) 1 M NaCl.  
 d) 
 f) 
 h)  g) 
 e) 
 c) 
 a) 
 j)  i) 
 b) 
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Figure 2.11 19F spectra (20 mM phosphate buffer, pH 6.0, 37 ° C) of 19F-labeled 
Kx7E in a) buffer and 300 g/L b) PEG, c) PVP, d) Ficoll, and e) BSA.  
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Figure 2.12 19F spectra (20 mM phosphate buffer, pH 6.0, 37 ° C) of 19F-labeled 
Kx7E in a) 585 g/L sucrose, b) 72% (v/v) glycerol, c) 300 g/L dextran, and d) 600 
g/L betaine. 
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Figure 2.13 19F spectrum (20 mM phosphate buffer, pH 6.0, 37 ° C) o f 19F-
labeled Kx7E in 300-610 g/L glucose. 
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Figure 2.14 HSQC spectra (25 ° C) of 15N-enriched wild-type ProtL and Kx7E in 
E. coli. a) Cell slurry producing the wild-type protein. b) Wild-type ProtL cell 
supernatant. c) Lysate of cells from a). d) Lysate of cells shown in a) upon adding 
NaCl to a final concentration of 1 M. e) Cell slurry producing the Kx7E variant. f) 
Kx7E cell supernatant. g) Lysate of cells from e). h) Lysate of cells shown in e) 
upon adding NaCl to a final concentration of 1 M.   
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Figure 2.15 HSQC spectrum (25 ° C) of E. coli without an expression vector. 
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Figure 2.16 19F spectra (37 ° C) of 19F-labeled wild-type ProtL and Kx7E in E. 
coli. a) Cell slurry producing wild-type protein. b) Supernatant from the sample 
used in a). c) Lysate of cells from a). d) Cell slurry producing the Kx7E variant. e) 
Supernatant from the sample used in d). f) Insoluble lysate fraction of cells from 
d) with 3 M guanidine chloride. g) Cell slurry producing the Kx7E variant grown 
and induced in hyperosmotic media. Asterisks denote the free 3-FY resonance.  
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Figure 2.17 HSQC spectra (25 ° C) of 15N-enriched Kx7E from E. coli. a) Lysate 
of cells producing the Kx7E variant. b) Lysate of cells shown in a) upon adding 
KCl to a final concentration of 1 M. 
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Figure 2.18 19F spectra (37 ° C) of 19F-labeled Kx7E from E. coli lysates. a) 
Cleared cell lysate. b) Insoluble lysate fraction resuspended in 20 mM phosphate 
buffer, pH 6.0. Asterisks denote the resonance from free 3-FY.  
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Figure 2.19 HSQC spectra (25 ° C) of 15N-enriched Kx6E and Kx6Q in E. coli. a) 
Cell slurry producing Kx6E. b) Kx6E cell supernatant. c) Lysate of cells from a). 
d) Lysate of cells shown in a) upon adding NaCl to a final concentration of 1 M. 
e) Cell slurry producing Kx6Q. f) Kx6Q cell supernatant. g) Lysate of cells from 
e). h) Lysate of cells shown in e) upon adding NaCl to a final concentration of 1 
M.  
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Figure 2.20 HSQC spectra (25 ° C) of 15N-enriched Kx6E in E. coli. a) Cell slurry 
producing Kx6E. b) Lysate of cells from a).   
 
 
  
Chapter 3 
Insect Cell Recombinant Protein Production for In-Cell NMR 
 
3.1   Introduction 
 The goal of this project is to examine properties of α-synuclein (α-syn) in 
higher eukaryotic cells by using in-cell NMR. The Pielak group has already 
obtained information about α-syn in Escherichia coli, so the next step is to 
observe α-syn in higher eukaryotic cells. By using in-cell nuclear magnetic 
resonance (NMR) spectroscopy, properties such as structure, diffusion, and 
dynamics can be assessed in higher eukaryotic cells and compared to data 
obtained in E. coli. As α-syn is a human protein, the rationale behind moving its 
study into higher eukaryotic cells is to provide an environment that is as 
physiologically relevant as possible. In this way, the observed α-syn properties 
will be applicable to its behavior and function in humans, thus potentially 
elucidating its pathogenic role in Parkinson’s disease. 
 NMR has been used to study proteins in E. coli and yeast and has 
provided valuable information about many recombinant proteins, but few in-cell 
NMR experiments have been performed in higher eukaryotic cells (70). 
Techniques for performing higher eukaryotic in-cell NMR are required to obtain 
physiologically relevant information about human proteins. Higher eukaryotic 
proteins often have additional requirements to function, such as posttranslational 
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modifications, which only higher eukaryotic cells can provide. The composition of 
higher eukaryotic cells is fundamentally different from that of prokaryotic cells, 
and thus human proteins must be studied in these higher order cells to obtain the 
most physiologically relevant data. 
Higher eukaryotic cells vary in composition from prokaryotic cells. They 
contain organelles, carry out post-translational modifications, and are not as 
crowded as prokaryotic cells (3, 19). The degree of crowding is expected to affect 
protein properties such as structure, binding affinity, and mobility (80). For 
example, the diffusion coefficient for the green fluorescent protein (GFP) is 
significantly higher in the cytoplasm of eukaryotic cells than in the E. coli 
cytoplasm (27 µm2/s versus 7.7 µm2/s, respectively) (2, 81). Additionally, the 
extent of crowding varies in some eukaryotic organelles, thus affecting protein 
properties. The rat liver mitochondrial matrix is more crowded than the cytosol 
(82). However, the diffusion coefficient of GFP in the mitochondrial matrix and 
cytoplasm are similar (2, 83), suggesting that some organization exists in the 
matrix to reduce crowding effects (83). These results demonstrate that significant 
differences exist between prokaryotic and higher eukaryotic cells and that these 
differences can change protein properties. 
Observation of proteins by in-cell NMR has been performed in a few 
higher eukaryotic cells. The first experiments were performed in Xenopus laevis 
oocytes (19, 26). Routine in-cell NMR studies, however, are not practical for 
several reasons. The test protein must be injected into each oocyte and each 
experiment requires many oocytes (~200). Consistency and efficiency in the 
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injection process also requires specialized equipment. Moreover, their large size 
makes maintaining cellular structural integrity, and thus viability, difficult over the 
duration of NMR experiments, although embedding the cells in Ficoll solutions 
helps to maintain oocyte integrity and prevent protein leakage (28). Other 
expression systems include mammalian cell lines, but these are difficult to 
develop and may not produce high enough levels of protein for in-cell NMR 
experiments. Despite these constraints, isotopically enriched recombinant 
proteins have been inserted into human HeLa cells by using cell penetrating 
peptides, and two-dimensional NMR spectra were obtained (84).  
Insect cell expression systems utilizing a recombinant baculovirus to 
produce the protein of interest provide a cheaper, safer alternative to many 
mammalian cells lines. Insect expression systems are relatively quick to set up 
and can produce high levels of recombinant protein (85-90). Additionally, insect 
cells provide a eukaryotic environment conducive to proper post-translational 
modifications (89). Therefore, insect cells were chosen as the higher eukaryotic 
cell type for production of human α-syn. 
The intrinsically disordered human protein α-syn is used as a model 
because intrinsically disordered proteins are observable by in-cell NMR in 
prokaryotes (17, 18, 49), and their physical properties are affected by 
macromolecular crowding (17, 18, 49, 91). α-Syn is also a relevant protein 
because of its involvement in Parkinson’s disease (92). Parkinson's disease is a 
neurological disorder resulting in tremors, rigid movement, and slowing of 
voluntary body motions that afflicts approximately 1-2% of individuals over 65 
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years of age (93). α-Syn forms fibrillar aggregates in cytoplasmic inclusions 
known as Lewy bodies, which are the clinical hallmark of Parkinson’s disease 
(92, 94). Additionally, the Pielak group has experience producing α-syn and 
performing in vitro NMR (95) and in-cell NMR in E. coli (18, 49, 52). 
The Pielak group has studied the effects of macromolecular crowding on 
α-syn structure in dilute solution, under crowded conditions in vitro, and in E. coli 
(18, 91, 96). Crowding in vitro and in E. coli prevents a temperature induced 
conformational change observed in dilute solution (Fig. 3.1) (18). α-Syn is 
disordered and collapsed in in vitro crowded solutions and in E. coli at 35 ° C but 
is extended and gains some structure in dilute solution at 35 ° C. 
The α-syn 1H-15N heteronuclear single-quantum coherence (HSQC) 
spectrum in dilute solution at 10 ° C contains about 70  crosspeaks (Fig. 3.1a) 
and is representative of a disordered protein, while the spectrum at 35 ° C 
contains about 30 crosspeaks (Fig. 3.1b). This difference has been attributed to 
an intermediate reversible conformational exchange that occurs on the chemical 
shift time scale where the first 100 amino acid residues of α-syn gain secondary 
structure (91). The remaining crosspeaks in dilute solution at 35 ° C are from the 
C-terminal disordered region. The α-syn disorder observed in dilute solution at 10 
° C is maintained in the in vitro crowded bovine serum albumin solution at 35 ° C 
(Fig. 3.1d) and in E. coli at 35 ° C (Fig. 3.1 c). Thus, these crowded environments 
prevent the temperature induced α-syn conformational change observed in dilute 
solution at 35 ° C. Additionally, the nearly identica l spectra in E. coli at 35 ° C  and 
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in vitro crowded solution at 35 ° C suggest that macromolecular cr owding alone 
is sufficient to maintain α-syn disorder. 
The time required for α-syn protofibril and mature fibril formation is 
shortened under in vitro crowded conditions (97, 98). These experiments suggest 
that changes in cell cytoplasmic concentration could promote formation of α-syn 
protofibrils and stabilize them (97). Some evidence shows that the total 
concentration of macromolecules in cells changes as individuals age. For 
example, cell volumes decrease in aged rats (99), and protein degradation is 
inhibited in brains of patients with Parkinson’s disease (100). Both situations 
could lead to an effective increase in the concentration of α-syn, promoting α-syn 
fibril formation. Furthermore, the reduced cellular viscosity in higher eukaryotes 
compared to prokaryotes may accelerate disease causing α-syn aggregates 
(101) due to increased diffusion (98). Therefore, studying the effects of 
macromolecular crowding on α-syn properties in higher eukaryotic cells should 
yield important insights into the molecular basis of Parkinson’s disease.  
No NMR information about α-syn in higher eukaryotic cells is available. 
Other intrinsically disordered proteins, such as the C-terminal activation domain 
of c-Fos and the kinase-inhibition domain of p27Kip1, have been shown not to 
undergo significant conformational changes in the presence of high 
concentrations of dextrans and Ficoll 70 as assessed by circular dichroism and 
fluorescence spectroscopy (102). These observations, coupled with data 
showing that E. coli maintains α-syn disorder, lead to the prediction that α-syn 
will also remain unfolded in insect cells. It is possible, however, that an increase 
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in α-syn diffusion and dynamics might be observed because higher eukaryotic 
cells are less crowded than E. coli.  
To observe α-syn by in-cell NMR in higher eukaryotic cells, the 
baculovirus expression system is used to generate a recombinant baculovirus 
containing the human α-syn gene for production of high levels of isotopically 
labeled α-syn in Spodoptera frugiperda 9 (Sf9) insect cells. Many recombinant 
proteins have been isotopically labeled in Sf9 cells by using the baculovirus 
expression system. In one of the earliest examples, recombinant rhodopsin was 
produced and labeled in Sf9 cells with deuterated tyrosines and analysed by 
Fourier transform infrared spectroscopy (103). Rhodopsin was also the first 15N-
enriched eukaryotic membrane protein to be analysed by solid state NMR, and it 
was produced and enriched in Sf9 cells (104). Brüggert et al. demonstrated 
selective 15N enrichment of purified glutathione-S-transferase protein produced in 
Sf9 insect cells (105). 
Previous work shows that α-syn can be produced in Sf9 insect cells (106). 
Production of sufficient concentrations of isotopically labeled α-syn for insect in-
cell NMR experiments, however, requires overcoming some technical hurdles. 
The first hurdle is tracking the progress of insect baculovirus infection so that α-
syn production may be followed. To overcome this hurdle, GFP is produced in 
insect cells either in parallel or as a fusion protein with α-syn. GFP has been 
successfully produced in baculovirus infected Sf9 cells (107) and is a convenient 
reporter protein due to its fluorescence; baculovirus infection and protein 
production can be followed under a fluorescent microscope (108). Furthermore, 
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the solution NMR spectra of 3-fluorotyrosine (3-FY)-labeled GFP (64) and 15N-
enriched GFP (109) are available, potentially aiding in the assessment of GFP 
spectra observed in Sf9 cells.   
The second hurdle is finding a culture media for the isotopic labeling of α-
syn and GFP in Sf9 cells. Commercial insect media for the isotopic labeling of 
recombinant proteins are prohibitively expensive. For example, 15N-enriched 
Bioexpress-2000 media from Cambridge Isotope Laboratories, Inc. is $7,500 per 
liter. Thus, custom media based on the formulation presented by Walton et al. 
(110) are prepared to isotopically enrich or label the recombinant proteins in Sf9 
cells at a fraction of the cost. The methods used to produce isotopically enriched 
or labeled α-syn and GFP in Sf9 cells and findings from in-cell NMR experiments 
are presented here. 
3.2   Materials and Methods 
3.2.1   Insect Cell Culture Growth and Maintenance 
Sf9 Cell Monolayer Culture 
Spodoptera frugiperda 9 (Sf9) cells (Lineberger Comprehensive Cancer 
Center Tissue Culture Facility, University of North Carolina at Chapel Hill [UNC-
CH]) were provided in 25-cm2 cell culture flasks in Grace's Medium and 10% 
heat inactivated fetal bovine serum (FBS). Cells were grown and passaged by 
dilution in Sf-900 II SFM (serum-free medium; Invitrogen Corp.; Carlsbad, CA) 
without antibiotics in 25-cm2 cell culture flasks (Corning, Inc. - Life Sciences; 
Wilkes-Barre, PA). Cells were grown at 27 ° C under ambient air conditions in an 
Isotemp Undercounter Refrigerated Incubator (Thermo Fisher Scientific, Inc.; 
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Dubuque, IA). Cells were passaged by dilution 1:10 with fresh media once 
monolayer confluency reached 80%-100%. Cell density and viability were 
determined with a hemocytometer (Hausser Scientific Co.; Horsham, PA) and 
0.4% trypan blue (Sigma-Aldrich Co.; St. Louis, MO) staining using an Axiovert 
40 CFL microscope (Carl Zeiss, Inc.; Thornwood, NY). All Sf9 cell culture work 
was performed in a Purifier Class II Biosafety Cabinet (Labconco Corp.; Kansas 
City, MO). 
Sf9 Cell Suspension Culture 
Sf9 cells (Lineberger Comprehensive Cancer Center Tissue Culture 
Facility, UNC-CH) were grown and passaged in Sf-900 II SFM without antibiotics. 
Cells were grown at 27 ° C under ambient air conditio ns in 125-mL and 250-mL 
spinner flasks (Corning, Inc. - Life Sciences) on a Thermolyne Type 45700 
Cellgro stirrer (Thermo Fisher Scientific, Inc.; Waltham, MA) at 70 rotations per 
minute (rpm). Cells were seeded at 0.5 x 106 cells/mL and passaged by dilution 
with fresh media to 0.5 x 106 cells/mL when cell densities reached >2 x 106 
cells/mL.  
Sf9 cells (Expression Systems, LLC; Woodland, CA) were grown and 
passaged in ESF 921 insect cell medium (Expression Systems, LLC) without 
antibiotics. Cells were grown as 20-mL suspension cultures in 125-mL 
Erlenmeyer shake flasks (Corning, Inc. - Life Sciences) with the solid caps 
vented half-a-turn. Cells were grown at 27 ° C under  ambient air conditions on an 
Orbit 1900 Heavy Duty Shaker (Labnet International, Inc.; Edison, NJ) at 150 
rpm. Cells were seeded at 0.5 x 106 cells/mL and passaged by dilution with fresh 
65 
 
media to 0.5 x 106 cells/mL when cell densities reached 6-8 x 106 cells/mL, 
generally after 5 days. Sf9 cells in suspension were passaged up to twelve times. 
Cell density and viability were determined with the hemocytometer and 0.4% 
trypan blue staining. All Sf9 cell culture work was performed in the Purifier Class 
II Biosafety Cabinet. 
Drosophila S2 Cell Monolayer Culture 
Drosophila Schneider 2 (S2) cells (Invitrogen Corp.) were grown in 25-cm2 
cell culture flasks in Schneider’s medium (Invitrogen Corp.) supplemented with 
10% heat inactivated FBS (Atlanta Biologicals, Inc.; Lawrenceville, GA). No 
antibiotics were added. S2 cells were grown at 27 ° C u nder ambient air 
conditions and passaged by dilution 1:10 with fresh media once monolayer 
confluency reached 80%-100%. Cells were passaged up to twelve times. Cell 
density and viability were determined with the hemocytometer and 0.4% trypan 
blue staining. All S2 cell culture work was performed in the Purifier Class II 
Biosafety Cabinet. 
3.2.2   Recombinant Baculovirus Production 
EGFP pFastBac Dual Vector 
The pFastBac Dual vector (Invitrogen Corp.) containing the enhanced 
green fluorescent protein (EGFP) gene under the p10 promoter was provided by 
Dr. Michael Miley of the Redinbo lab in the Department of Chemistry, UNC-CH.  
α-Syn pFastBac 1 Vector 
The α-syn gene from the PT7-7 vector (18) was mutated using a site-
directed mutagenesis kit (Agilent Technologies, Inc.; Santa Clara, CA) to remove 
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the internal EcoRI site and amplified by using polymerase chain reaction (PCR) 
with primers 5’ CTTTAAGAAGGAGAATTCATATGGATGTATTCATG 3’ and       
5’ GAACATCTGTCAGCAGAATTCAAGAAACTGGGAGC 3’ (111) and Vent DNA 
polymerase (New England Biolabs, Inc.; Ipswich, MA) in an Eppendorf 
Mastercycler (Eppendorf North America; Hauppauge, NY). Both primers contain 
the EcoRI restriction site. The PCR reaction products were separated on 1% 
(w/v) agarose (Sigma-Aldrich Co.) gels electrophoresed at 100 V for 30 min. The 
amplified α-syn gene was excised and purified by using a gel extraction kit 
(Qiagen, Inc.; Germantown, MD). The α-syn PCR product and the pFastBac 1 
vector (Invitrogen Corp.) were digested with EcoRI (New England Biolabs, Inc.) 
and purified by agarose gel electrophoresis followed by gel extraction. The 
digested products were mixed and ligated with Quick T4 DNA ligase (New 
England Biolabs, Inc.) and transformed into DH5α E. coli cells (Invitrogen Corp.). 
Cells were streaked onto Luria broth (LB) plates containing 100 µg/mL ampicillin 
(LBAMP; Thermo Fisher Scientific, Inc.; Fair Lawn, NJ) and incubated overnight at 
37 ° C. Colonies were picked from the plates and used to  inoculate 5-mL liquid 
cultures of LBAMP and grown for 12-16 h at 37 ° C with 250-rpm shaking . α-Syn 
pFastBac 1 DNA was isolated by using a miniprep kit (Qiagen, Inc.; Valencia, 
CA) and sequenced (UNC-CH Genome Analysis Facility) to identify constructs 
with the α-syn gene inserted into the vector in the proper orientation.  
α-Syn pUltraBac-1 and α-Syn-EGFP pUltraBac-1 Vectors 
The pUltraBac-1 vector containing the EGFP gene under a late basic 
protein promoter (PBasic) was provided by Felix Freuler (Novartis International AG; 
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Basel, Switzerland). To generate the α-syn pUltraBac-1 vector, the α-syn gene 
from the PT7-7 vector was amplified by using PCR with primers 5’ GAAATAATTT 
TGTTTAACCTCGAGAAGGAGATATACATATGGATG 3’ and 5’ GAAACTGGGA 
GCAATGCATATTTCTTAGGCTTCAGGTTC 3’ containing XhoI and NsiI 
restriction sites, respectively. To generate the α-syn-EGFP pUltraBac-1 vector, 
the α-syn gene from the PT7-7 vector was amplified by using PCR with primers 
5’ GAAATAATTTTGTTTAACCTCGAGAAGGAGATATACATATGGATG 3’ and   
5’ GTAACACTCGAGAGGCTTCAGGTTCGTAGTCTTGATACC 3’. Both contain 
the XhoI restriction sites. The PCR reaction products were separated on 1% 
(w/v) agarose gels electrophoresed at 100 V for 55 min. The amplified α-syn 
genes were excised and purified by using the gel extraction kit. The pUltraBac-1 
vector and the α-syn PCR product for α-syn pUltraBac-1 vector generation were 
digested with XhoI and NsiI (New England Biolabs, Inc.). The pUltraBac-1 vector 
and the α-syn PCR product for α-syn-EGFP pUltraBac-1 vector generation were 
digested with XhoI. The digested products were separated by agarose gel 
electrophoresis and purified by using the gel extraction kit. The digested products 
were mixed and ligated with T4 DNA ligase (New England Biolabs, Inc.) 
overnight at 16 ° C and transformed into DH5 α E. coli. Cells were streaked onto 
LBAMP plates and incubated overnight at 37 ° C. Liquid cu ltures of LBAMP (5 mL) 
were inoculated with colonies from the LBAMP plates and grown for 12-16 h at 37 
° C with 250-rpm shaking.  The α-syn pUltraBac-1 and α-syn-EGFP pUltraBac-1 
vector DNA was isolated by using the miniprep kit and checked by restriction 
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enzyme mapping and DNA sequence analysis to identify constructs containing 
the α-syn gene inserted into the vector in the proper orientation. 
Recombinant Bacmids 
Recombinant bacmids and baculoviruses were generated as described in 
the instructions for the Bac-to-Bac Baculovirus Expression System (Invitrogen 
Corp.). The EGFP pFastBac Dual, α-syn pFastBac 1, α-syn pUltraBac-1, or α-
syn-EGFP pUltraBac-1 vector DNA were transformed into DH10Bac E. coli cells 
(Invitrogen Corp.) to allow transposition into the DH10Bac bacmid. Cells were 
streaked onto LB plates containing 50 µg/mL kanamycin (Thermo Fisher 
Scientific, Inc.; Fair Lawn, NJ), 7 µg/mL gentamicin (MP Biomedicals, LLC; 
Solon, OH), 10 µg/mL tetracycline (Thermo Fisher Scientific, Inc.; Fair Lawn, NJ), 
100 µg/mL Bluo-gal (Invitrogen Corp.), and 40 µg/mL isopropyl-β-D-1-
thiogalactopyranoside (IPTG; Thermo Fisher Scientific, Inc.; Fair Lawn, NJ) for 
blue/white colony selection. Positive colonies were selected and the recombinant 
bacmids purified as described by the manufacturer.  
EGFP pFastBac Dual and α-Syn pFastBac 1 Recombinant Baculoviruses 
 Transfection mixtures comprising 1 µg of EGFP pFastBac Dual 
recombinant bacmid or 1 µg of α-syn pFastBac 1 recombinant bacmid and 6 µL 
of Cellfectin (Invitrogen Corp.) were added to each well of a 6-well plate 
(Corning, Inc. - Life Sciences) seeded with 1 x 106 Sf9 cells/well. After 5 h of 
incubation, the DNA:lipid complexes were removed. Two mL of Sf-900 II SFM 
were added to each well of the 6-well plates. The plates were incubated at 27 ° C 
for 72 h. Cell culture media were collected and centrifuged in a Centrific Model 
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228 centrifuge with a 232 rotor (Thermo Fisher Scientific, Inc.; Pittsburgh, PA) at 
1,380 x g for 5 min at room temperature to remove cell debris. The supernatants 
are the P1 baculovirus stocks. The P1 stocks were added to Sf9 cells in 
suspension (2 x 106 cells/mL) at a multiplicity of infection (MOI, number of 
infectious particles per cell) of 0.1, and the resulting cell cultures were incubated 
at 27 ° C with 150-rpm shaking. The desired amount of virus (in mL) is calculated 
by multiplying the desired MOI by the total number of cells and then dividing by 
the titer of the baculovirus stock. Cell culture media were collected 48 h post 
infection (p.i.) to generate the P2 stocks. P3 stocks were generated from the P2 
stocks in the same way. The P1, P2, and P3 stocks were not titered, but the 
concentrations were assumed to be 5 x 106 plaque forming units (pfu) per mL, 5 
x 107 pfu/mL, and 1 x 108 pfu/mL, respectively, as suggested by the 
manufacturer. The baculovirus stocks were stored at 4 ° C.  
α-Syn pUltraBac-1 and α-Syn-EGFP pUltraBac-1 Recombinant Baculoviruses 
Transfection mixtures comprising 15 µg of α-syn pUltraBac-1 recombinant 
bacmid or 15 µg of α-syn-EGFP pUltraBac-1 recombinant bacmid and 70 µL of 
Cellfectin II (Invitrogen Corp.) were added to 75-cm2 cell culture flasks (Corning, 
Inc. - Life Sciences) seeded with 1.3 x 107 Sf9 cells per culture flask. After 5 h, 
the DNA:lipid complexes were removed, and 15 mL of ESF 921 media were 
added to each flask. The flasks were incubated at 27 ° C for 72 h. Cell culture 
media were collected and centrifuged in the Centrific Model 228 centrifuge at 
1,380 x g for 3 min at room temperature to remove cell debris. The supernatants 
are the P1 baculovirus stocks. The P1 stocks were added to 25 mL of Sf9 cells in 
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suspension (2 x 106 cells/mL) at a MOI of 0.1, and the cell cultures were 
incubated at 27 ° C with 150-rpm shaking. The P1 stock s were not titered but 
assumed to be 5 x 106 pfu/mL as suggested by the manufacturer. Cell culture 
media were collected 72 h p.i. when the majority (83%) of Sf9 cells infected with 
α-syn-EGFP pUltraBac-1 recombinant baculovirus fluoresced green. The α-syn-
EGFP pUltraBac-1 P2 stock was titered in a 96-well plate (Corning, Inc. - Life 
Sciences) based on the number of green-fluorescing Sf9 cells by using the 50% 
tissue culture infectious dose method (TCID50) (112). The titer of the α-syn 
pUltraBac-1 P2 stock was assumed to be the same. Each P2 stock was used to 
infect five 50-mL Sf9 suspension cultures (3 x 106 cells/mL) at a MOI of 0.1 to 
generate the P3 stocks. The cell suspensions were harvested 48 h p.i. and 
centrifuged in the Centrific Model 228 centrifuge at 1,380 x g for 5 min to pellet 
the cells. The media were sterile filtered with 0.22 µm polyvinylidene difluoride 
(PVDF) filters (EMD Millipore; Billerica, MA) into Nalgene Oak Ridge high speed 
centrifuge tubes (Thermo Fisher Scientific, Inc.; Rochester, NY) and centrifuged 
in a Sorvall RC-5B centrifuge with a Sorvall SS-34 rotor (Thermo Fisher 
Scientific, Inc.; Waltham, MA) at 19,000 rpm for 1 h at 4 ° C.  The supernatants 
were decanted and the baculovirus pellets resuspended in a total of 1.2 mL 
Dulbecco’s Phosphate Buffered Saline (PBS), without addition of CaCl2 and 
MgCl2 (Sigma-Aldrich Co.). The titer of the α-syn-EGFP pUltraBac-1 P3 stock 
was determined to be 8.47 x 109 pfu/mL as described above. The titer of the α-
syn pUltraBac-1 P3 stock was assumed to be the same. The baculovirus stocks 
were stored at 4 ° C. 
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3.2.3   Insect Cell Recombinant Protein Production and Visualization 
EGFP Production and Visualization  
 Sf9 suspension cells were grown to 2 x 106 cells/mL in Sf-900 II SFM 
using 250-mL spinner flasks and infected with P3 EGFP pFastBac Dual 
recombinant baculovirus stock (1 x 108 pfu/mL) at a MOI of 10. Fluorescent cells 
were visualized with a Zeiss 510 Meta Laser Scanning Confocal Microscope 
(Michael Hooker Microscopy Facility, UNC-CH). Cells were harvested 72 h p.i. by 
centrifugation in the Centrific Model 228 centrifuge at 1,380 x g for 2 min and 
resuspended in 2% sodium dodecyl sulfate (SDS) lysis buffer (2% [w/v] SDS, 
62.5 mM Tris-HCl, pH 6.7, 15% [v/v] glycerol, 0.1% [w/v] bromophenol blue 
[Sigma-Aldrich Co.]). Lysates were loaded onto 18% Tris-HCl SDS 
polyacrylamide gels (Bio-Rad Laboratories, Inc.; Hercules, CA). Gels were 
electrophoresed at 200 V for 50 min. EGFP fluorescence was detected by using 
a VersaDoc 4000 MP Imaging System (Bio-Rad Laboratories, Inc.) and 
correlated to protein concentration by measuring band densities with the built-in 
software. After scanning, gels were stained with Brilliant Blue R-250 (Thermo 
Fisher Scientific, Inc.; Pittsburgh, PA). Gels were then destained in aqueous 
solutions containing 40% (v/v) methanol and 10% (v/v) acetic acid followed by 
final destaining in a 10% methanol, 10% acetic acid solution. 
α-Syn Production and Visualization 
Sf9 suspension cells were grown to 1.5 x 106 cells/mL in Sf-900 II SFM by 
using 125-mL spinner flasks and infected with P3 α-syn pFastBac 1 recombinant 
baculovirus stock (1 x 108 pfu/mL) at a MOI of 10. Cells were harvested every 24 
72 
 
h p.i. for 8 days, centrifuged in the Centrific Model 228 centrifuge at 1,380 x g for 
5 min, and resuspended in 2% SDS lysis buffer. Lysates were loaded onto 18% 
Tris-HCl SDS polyacrylamide gels and electrophoresed at 200 V for 65 min. 
Western blotting was performed by transferring gel contents to PVDF 
membranes (Bio-Rad Laboratories, Inc.) and electrophoresing at 150 mA for 120 
min. The membranes were blocked with 5% (w/v) non-fat dry milk (LabScientific, 
Inc.; Livingston, NJ) solutions. A 2000x dilution of α-syn sc-12767 mouse 
monoclonal antibody (Santa Cruz Biotechnology, Inc.; Santa Cruz, CA) was 
added to bind α-syn. Excess antibody was washed off, and a 4000x dilution of 
goat anti-mouse immunoglobulin G horse radish peroxidase (IgG-HRP sc-2005, 
Santa Cruz Biotechnology, Inc.) was added to the membranes. HRP 
chemiluminescence was generated by using a Pierce ECL Western Blotting 
Substrate kit (Thermo Fisher Scientific, Inc.; Rockford, IL) and detected with the 
VersaDoc 4000 MP Imaging System. α-Syn levels were quantified with the built-
in software. 
α-Syn and α-Syn-EGFP Production and Visualization 
Sf9 cells in suspension were seeded in 125-mL spinner flasks to a final 
density of 1.9 x 106 cells/mL in ESF 921 media (9 mL total suspension volume) 
and infected with P2 α-syn pUltraBac-1 or P2 α-syn-EGFP pUltraBac-1 
recombinant baculovirus stock (5.85 x 106 pfu/mL) at a MOI of 1. Fluorescent 
cells were visualized with the Axiovert 40 CFL microscope equipped with a HBO 
50 ac mercury lamp (Carl Zeiss, Inc.). One-mL aliquots of cell suspensions were 
collected 48 h and 72 h p.i. and centrifuged in a Centrifuge 5418 benchtop 
73 
 
centrifuge (Eppendorf North America) at 1,400 x g for 2 min. Cell density and 
viability were determined with the hemocytometer and 0.4% trypan blue staining. 
The pellets were resuspended in Triton X-100 lysis buffer (25 mM sodium 
phosphate buffer, pH 7.0, 150 mM NaCl, 1% Triton X-100 [Sigma-Aldrich Co.]). 
Lysates were loaded onto 18% Tris-HCl SDS polyacrylamide gels and 
electrophoresed at 200 V for 65 min. EGFP fluorescence detection followed by 
western blotting for α-syn detection were performed as described above. 
3.2.4   Sf9 Custom Media for α-Syn Production 
Custom Insect Media Preparation 
Algal amino acid mix and Cell Free amino acid mix were from Cambridge 
Isotope Laboratories, Inc. (Andover, MA). Dialyzed yeastolate and ESF NMR 
medium lacking amino acids, NaCl, and yeastolate were from Expression 
Systems, LLC. L-Glutamine, L-glutamate, L-cysteine, L-tryptophan, L-asparagine, 
NaCl, and NH4Cl were from Thermo Fisher Scientific, Inc. (Fair Lawn, NJ). The 
ESF NMR medium has been discontinued by the manufacturer. 
The custom insect medium comprised the following components at their 
final concentrations in ESF NMR medium: 1.5 g/L algal amino acid mix, 0.5 g/L L-
glutamine, 2 g/L L-glutamate, 0.1 g/L L-cysteine, 0.1 g/L L-tryptophan, 4% (v/v) 
dialyzed yeastolate, and 4.3 g/L NaCl. Additional custom media were prepared 
as described above but with the addition of final concentrations of 0.1 g/L L-
asparagine or 0.8 g/L NH4Cl or both. Another custom medium comprised the 
following components at their final concentrations in ESF NMR medium: 1.5 g/L 
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Cell Free amino acid mix, 4% (v/v) dialyzed yeastolate, and 4.3 g/L NaCl. 
Custom media were prepared at 100-mL volumes.  
The osmolalities of the custom media were measured with a Vapro 5520 
Vapor Pressure Osmometer (Wescor, Inc.; Logan, UT) and adjusted to 350-400 
mOsm with NaCl. The pH values were adjusted to 6.2-6.3 with 4 M NaOH. Using 
aseptic technique, the custom media were filtered through 0.22 µm PVDF filters 
in the Purifier Class II Biosafety Cabinet. 
Sf9 Cell Growth and Viability in Custom Insect Media 
 Sf9 suspension cells maintained in ESF 921 media and 125-mL 
Erlenmeyer shake flasks were pelleted by centrifugation in the Centrific Model 
228 centrifuge at 1,380 x g for 2 min and resuspended in 15 mL of custom media 
to a final cell density of 1 x 106 cells/mL. Cells were incubated at 27 ° C with 100-
rpm shaking in 125-mL Erlenmeyer shake flasks. Cell aliquots of 100 µL were 
removed about every 24 h for 6 days. Cell density and viability were determined 
with the hemocytometer and 0.4% trypan blue staining. 
α-Syn Production in Custom Media Upon Recombinant Baculovirus Infection 
Sf9 suspension cells maintained in ESF 921 media in 125-mL Erlenmeyer 
shake flasks were pelleted by centrifugation in the Centrific Model 228 centrifuge 
at 1,380 x g for 2 min and resuspended in 17 mL of each of the five custom 
media described above and ESF 921 media to a final cell density of 1 x 106 
cells/mL. The suspension cultures were infected with P3 α-syn pFastBac 1 
recombinant baculovirus stock (1 x 108 pfu/mL) at a MOI of 3 and incubated at 27 
° C with 100-rpm shaking in 125-mL Erlenmeyer shake fl asks. Cell aliquots of 
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100 µL were removed about every 24 h p.i. for 6 days, and cell density and 
viability were determined with the hemocytometer and 0.4% trypan blue staining. 
Additional 1-mL aliquots for each cell suspension were removed every day, 
centrifuged in the Centrific Model 228 centrifuge at 1,380 x g for 3 min, and 
resuspended in 2% SDS lysis buffer. α-Syn levels from whole cell lysates were 
determined by western blotting as described in 3.2.3. Additional infections were 
performed at a MOI of 3 with P4 α-syn recombinant baculovirus at 1.8 and 3.6 x 
108 pfu/mL. The titers were determined by using a FastPlax Titer Kit (EMD 
Biosciences, Inc.; San Diego, CA). The custom medium for these infections 
comprised the following components at their final concentrations in ESF NMR 
medium: 1 g/L algal amino acid mix, 0.5 g/L L-glutamine, 2 g/L L-glutamate, 0.1 
g/L L-cysteine, 0.1 g/L L-tryptophan, 0.1 g/L L-asparagine, 0.8 g/L NH4Cl, 20% 
(v/v) dialyzed yeastolate, and 4.5 g/L D-glucose. Fifty mL of the custom medium 
was prepared. Osmolality quantification, pH determination, and sterile filtering 
were performed as described above. Sf9 cells were resuspended in 15 mL of the 
custom medium to a final cell density of 2 x 106 cells/mL and transferred to 125-
mL Erlenmeyer shake flasks. The suspension cultures were infected and 
incubated at 27 ° C with 125-rpm shaking. Aliquots of 4 mL were removed on 
days 3 and 4 p.i. for detection of α-syn by western blotting as described above. 
3.2.5   InsectDirect 
pIEx-7 Vector Construction and Purification 
Insect GeneJuice Transfection Reagent, InsectDirect pIEx-7 enterokinase 
ligation-independent cloning (Ek/LIC) Vector Kit (including NovaBlue GigaSingles 
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competent cells and T4 DNA polymerase LIC-qualified), and Insect Robopop Ni-
NTA (nickel-nitrilotriacetic acid) His-Bind Purification Kit were from EMD 
Biosciences, Inc. The IE1 promoter and AS S-tag primers used for DNA 
sequence analysis are shown in Table 3.1 and were ordered from Sigma-Aldrich 
Co. The EndoFree Plasmid Maxi Kit was from Qiagen, Inc.  
Primers for PCR amplification of human wild-type cytochrome c, human 
wild-type α-syn, Aequorea coerulescens GFP (AcGFP), ubiquitin, and human 
heat shock protein 1 (HSP27) genes were designed according to directions in the 
pIEx-7 Ek/LIC Vector Kit and ordered from Sigma-Aldrich Co. (Table 3.2). PCR 
reactions were performed with the primers and template vectors (Table 3.2) by 
using Vent DNA polymerase and the Eppendorf Mastercycler. PCR reaction 
products were separated on 1% (w/v) agarose gels electrophoresed at 100 V for 
50 min. The amplified Ek/LIC gene inserts were excised and purified with the gel 
extraction kit. Ek/LIC PCR amplified inserts were treated with T4 DNA 
polymerase and annealed into the pIEx-7 vector according to the manufacturer’s 
directions. The annealing reactions were transformed into NovaBlue GigaSingles 
competent cells, streaked onto LBAMP plates, and incubated overnight at 37 ° C. 
Colonies were picked from the plates and used to inoculate 5-mL liquid cultures 
of LBAMP and grown for 12-16 h at 37 ° C with shaking at 250 rpm. Plasmid DNA 
was isolated by using the miniprep kit. The DNA was checked by restriction 
enzyme mapping and DNA sequence analysis using pIEx-7 sequencing primers 
(Table 3.1) to verify insertion of the target genes into the pIEx-7 vector. 
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Positive colonies were used to inoculate 5-mL liquid cultures of LBAMP. 
The cultures were grown for 8 h at 37 ° C with shaking  at 250 rpm and used (0.5 
mL) to inoculate 100 mL of fresh LBAMP in 500-mL baffled flasks. These cultures 
were grown overnight at 37 ° C with shaking at 250 rp m, transferred to 250-mL 
centrifuge bottles, and centrifuged in the Sorvall RC-5B centrifuge with a Sorvall 
GSA rotor (Thermo Fisher Scientific, Inc.; Waltham, MA) at 6,000 rpm for 10 min 
at 4 ° C. Plasmid DNA was purified from the cell pel lets by using the EndoFree 
Plasmid Maxi Kit and resuspended in 0.5 mL of Tris ethylenediaminetetraacetic 
acid (EDTA) buffer (TE buffer). DNA yields were generally 1-2 µg/µL. 
InsectDirect Sf9 Recombinant pIEx-7 Transfection and Protein Production 
 Ten-mL aliquots of Sf9 suspension cultures were transfected with pIEx-7 
purified DNA containing the gene of interest by using the Insect GeneJuice 
Transfection Reagent according to the manufacturer’s directions. Suspension 
cultures were incubated at 27 ° C with shaking at 150 r pm for 48 h. Suspension 
cultures were lysed and the recombinant proteins purified with the Insect 
Robopop Ni-NTA His-Bind Purification Kit according to the manufacturer’s 
directions. The purified recombinant proteins were loaded onto 18% Tris-HCl 
SDS polyacrylamide gels and electrophoresed at 200 V for 65 min. Protein yields 
were determined in triplicate by using a Pierce Modified Lowry Protein Assay Kit 
(Thermo Fisher Scientific, Inc.; Rockford, IL) with cytochrome c as a standard.  
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3.2.6   Drosophila S2 Cell Infection 
pUAST-AcGFP and pUltraBac-1 Vector Construction 
The AcGFP gene was PCR amplified (primers are presented in Table 3.3) 
by using the template pAcGFP1 vector (Clontech; Mountain View, CA), Vent 
DNA polymerase, and the Eppendorf Mastercycler. PCR reaction products were 
separated on 1% (w/v) agarose gels electrophoresed at 100 V for 55 min. The 
amplified AcGFP gene was excised and purified by using the gel extraction kit. 
The AcGFP PCR product and the pUAST vector containing the Drosophila heat 
shock protein 70 (hsp70) promoter (Drosophila Genomics Resource Center; 
Bloomington, IN) were digested with KpnI and XbaI (New England Biolabs, Inc.). 
The reaction products were separated by agarose gel electrophoresis and the 
relevant species isolated by gel extraction. The digested products were mixed 
and ligated with T4 DNA ligase overnight at 16 ° C a nd transformed into DH5α E. 
coli. Cells were streaked onto LBAMP plates and incubated overnight at 37 ° C. 
Colonies were picked from the plates and used to inoculate 5-mL liquid cultures 
of LBAMP and grown for 12-16 h at 37 ° C with shaking at 250 rpm. pUAST-
AcGFP DNA was isolated with the miniprep kit and checked by restriction 
enzyme mapping and DNA sequence analysis to identify constructs with the 
AcGFP gene inserted into the hsp70 promoter multiple cloning site (MCS) of the 
pUAST vector.  
Mutagenesis reactions (primers are presented in Table 3.4) to introduce 
HindIII and BamHI restriction sites into the pUltraBac-1 vector were performed by 
using the site-directed mutagenesis kit. The mutagenesis reactions were 
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transformed into XL 10-Gold E. coli cells (Agilent Technologies, Inc.) and grown 
overnight in 5 mL of LBAMP at 37 ° C with 250-rpm shaking. Plasmid DNA was 
isolated with the miniprep kit. The identities of the mutants were confirmed by 
restriction enzyme mapping and DNA sequence analysis.   
pUAST-AcGFP and pUltraBac-1 were digested with HindIII and BamHI 
(New England Biolabs, Inc.). The reaction products were separated by agarose 
gel electrophoresis and the relevant species isolated by gel extraction as 
described above. The hsp70-AcGFP fragment and the digested pUltraBac-1 
vector were mixed and ligated with T4 DNA ligase overnight at 16 ° C and 
transformed into DH5α E. coli. Cells were streaked onto LB plates containing 100 
µg/mL ampicillin and 7 µg/mL gentamicin (LBAMP/GEM) and incubated overnight at 
37 ° C. Positive colonies were picked and used to inocu late 5-mL liquid cultures 
of LBAMP/GEM. The cultures were grown for 12-16 h at 37 ° C with 250-rpm 
shaking. pUltraBac-1-hsp70-AcGFP DNA was isolated by using the miniprep kit. 
The identity of the constructs was confirmed by restriction enzyme mapping and 
DNA sequence analysis. 
pUltraBac-1-hsp70-AcGFP Recombinant Baculovirus Generation 
pUltraBac-1-hsp70-AcGFP DNA was transformed into DH10Bac E. coli 
cells to allow transposition into the DH10Bac bacmid. The cells were streaked 
onto LB plates containing 50 µg/mL kanamycin, 7 µg/mL gentamicin, 10 µg/mL 
tetracycline, 100 µg/mL Bluo-gal (Invitrogen Corp.), and 40 µg/mL IPTG for 
blue/white selection. Positive colonies were selected and the recombinant 
bacmid purified as described by the manufacturer.  
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A transfection mixture comprising 15 µg of pUltraBac-1-hsp70-AcGFP 
recombinant bacmid and 70 µL of Cellfectin II (Invitrogen Corp.) was added to a 
75-cm2 cell culture flask seeded with 5 x 106 Sf9 cells. After 5 h, the DNA:lipid 
complex was removed and 15 mL of ESF 921 medium was added. The flask was 
incubated at 27 ° C for 72 h. The culture medium was collected and centrifuged 
in the Centrific Model 228 centrifuge at 1,380 x g for 2 min to remove cell debris. 
The supernatant is the P1 baculovirus stock. The P1 stock was titered in a 96-
well plate based on the number of green-fluorescing Sf9 cells from the TCID50. 
The P1 stock was added at a MOI of 0.1 to 10 mL of Sf9 suspension cells at 2 x 
106 cells/mL in ESF 921 medium. The medium was collected 48 h p.i. to 
generate the P2 stock and was titered as described above. The P2 stock was 
used to infect five 50-mL Sf9 suspension cultures (2 x 106 cells/mL) at a MOI of 
0.1 to generate the P3 stock. The cell suspensions were harvested 48 h p.i. and 
centrifuged in the benchtop centrifuge at 500 x g for 5 min to pellet the cells. The 
medium was sterile filtered with 0.22 µm PVDF filters into Nalgene Oak Ridge 
high speed centrifuge tubes and centrifuged in the Sorvall RC-5B centrifuge with 
the Sorvall SS-34 rotor at 19,000 rpm for 2 h at 4 ° C. The medium was decanted 
and the baculovirus pellet resuspended in a total of 1.2 mL PBS. The titer of the 
P3 stock was determined to be 5.85 x 109 pfu/mL as described above. All 
baculovirus stocks were stored at 4 ° C. 
Drosophila S2 Cell Infection 
S2 cells were seeded in a 24-well tissue culture plate (Corning, Inc. - Life 
Sciences) at 1 x 106 cells/well and infected with P3 pUltraBac-1-hsp70-AcGFP 
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recombinant baculovirus at MOIs of 1, 10, 50, 100, and 200. Cells were 
harvested 36 h p.i., and cell viability was checked with the hemocytometer and 
0.4% trypan blue staining. Cells were centrifuged in the Centrific Model 228 
centrifuge at 1,380 x g for 2 min and resuspended in 2% SDS lysis buffer. 
Lysates were loaded onto 18% Tris-HCl SDS polyacrylamide gels and 
electrophoresed at 200 V for 50 min. AcGFP fluorescence detection, gel staining, 
and gel destaining were performed as described in 3.2.3. 
3.2.7   EGFP Production in Sf9 Cells with pUltraBac-1-hsp70-AcGFP  
Custom Insect Media 
The custom algal medium comprised the following components at their 
final concentrations in ESF NMR medium: 3 g/L algal amino acid mix, 2 g/L L-
glutamine, 0.4 g/L L-glutamate, 0.1 g/L L-cysteine, 0.1 g/L L-tryptophan, 0.1 g/L L-
asparagine, 7.3 g/L D-glucose, and 20% (v/v) dialyzed yeastolate. Forty mL of 
this custom medium was prepared. The twenty amino acid (20 A.A.) custom 
medium comprised the following components at their final concentrations in ESF 
NMR medium: 3 g/L Cell Free amino acid mix, 7.3 g/L D-glucose, and 20% (v/v) 
dialyzed yeastolate. Forty mL of this custom medium was prepared. Variable 
yeastolate custom algal media were prepared as described above for the custom 
algal medium but with the addition of final concentrations of 0%, 2%, or 10% (v/v) 
dialyzed yeastolate and 2.16 g/L mannose, 3.61 g/L glucose, 1.20 g/L galactose, 
0.38 g/L fructose, and 1.75 g/L sucrose instead of 7.3 g/L glucose to more 
accurately mimic the sugar composition of commercial ESF 921 media (113). 
Ten mL of each of the three variable yeastolate media were prepared. “No 
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yeastolate, no tryptophan” custom algal medium was prepared as described 
above for the variable yeastolate custom algal media but without addition of 
dialyzed yeastolate and tryptophan, respectively. Ten mL of this custom medium 
was prepared. Amino acid custom media containing all 20 ribosomally encoded 
amino acids (20 individual A.A.), 19 individual A.A., or no A.A. comprised 
individual amino acids and sugars (final concentrations are given in Table 3.5) in 
ESF NMR medium. The amino acid concentrations for 20 and 19 individual A.A. 
media mimicked the composition of 3 g/L algal amino acid mix. Twenty mL of 
each medium was prepared. The individual amino acids are from Sigma-Aldrich 
Co. The sugars are from Thermo Fisher Scientific, Inc. (Fair Lawn, NJ). Materials 
and further information on preparation of custom media, including osmolality 
quantification and sterile filtering, are described in 3.2.4. 
EGFP Production in Commercial and Custom Insect Media 
 Routinely maintained Sf9 suspension cultures in ESF 921 media were 
pelleted by centrifugation in the Centrific Model 228 centrifuge at 1,380 x g for 2 
min. Cell pellets were resuspended to a final density of 2 x 106 cells/mL in ESF 
921 medium, custom algal medium with or without 5% ESF 921 medium, 20 A.A. 
custom medium with or without 5% ESF 921 medium, variable yeastolate custom 
algal media, “no yeastolate, no tryptophan” custom algal medium, 20 individual 
A.A., 19 individual A.A., and no A.A. custom media. Ten mL of each Sf9 
suspension culture were added to 125-mL Erlenmeyer shake flasks and infected 
with P3 pUltraBac-1-hsp70-AcGFP recombinant baculovirus at a MOI of 1 (MOI 
of 3 for 20 individual A.A., 19 individual A.A., and no A.A. custom media). 
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Baculovirus titers were determined from the TCID50. Cell aliquots of 100 µL were 
removed through 72 h p.i. to determine cell density and viability with the 
hemocytometer and 0.4% trypan blue staining. Cells were centrifuged in the 
Centrific Model 228 centrifuge at 1,380 x g for 2 min and resuspended in 1% lysis 
buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1% Triton X-100). Lysates were 
loaded onto 18% Tris-HCl SDS polyacrylamide gels and electrophoresed at 200 
V for 50 min. EGFP fluorescence detection was performed as described in 3.2.3. 
Sf9 Cell Viability in the NMR Tube 
 Routinely maintained Sf9 suspension cultures in ESF 921 medium were 
centrifuged in the Centrific Model 228 centrifuge at 1,380 x g for 2 min. The 
medium was decanted and the cell pellet (200 µL) added to a S500 NMR tube 
(Norell, Inc.; Landisville, NJ) at room temperature. Cell viability was checked after 
3 h, 6 h, 21 h, and 25 h by removing 100 µL aliquots of cells and counting on the 
hemocytometer using a Live/Dead Viability/Cytotoxicity kit (Invitrogen Corp.).   
5-Fluorotryptophan Custom Algal Amino Acid Media Preparation 
 5-Fluorotryptophan (5-FW; Sigma-Aldrich Co.) was used to prepare 19F-
labeled custom algal medium as described in 3.2.7 except that 0.1 g/L tryptophan 
was replaced by 0.1 g/L 5-FW, and 7.3 g/L glucose was replaced by 2.16 g/L 
mannose, 3.61 g/L glucose, 1.20 g/L galactose, 0.38 g/L fructose, and 1.75 g/L 
sucrose to more accurately mimic the sugar composition of commercial ESF 921 
media (113). Forty mL of this custom medium was prepared. 
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Sf9 EGFP Production in 5-FW Custom Algal Media 
 Routinely maintained Sf9 suspension cultures in ESF 921 media were 
pelleted by centrifugation in the Centrific Model 228 centrifuge at 1,380 x g for 2 
min. Cell pellets were resuspended to a final density of 2 x 106 cells/mL in 5-FW 
custom algal media (9 mL) and infected with P3 pUltraBac-1-hsp70-AcGFP 
recombinant baculovirus at a MOI of 3. Baculovirus titers were determined from 
the TCID50. Cell aliquots of 100 µL were removed prior to infection and 24 h, 48 
h, and 72 h p.i. to determine the cell density and the viability with the 
hemocytometer and 0.4% trypan blue staining. To detect EGFP, cells were 
centrifuged in the Centrific Model 228 centrifuge at 1,380 x g for 2 min and 
resuspended in 1% lysis buffer. Lysates were loaded onto 18% Tris-HCl SDS 
polyacrylamide gels and electrophoresed at 200 V for 50 min. EGFP 
fluorescence detection was performed as described in 3.2.3. 
Production of 5-FW-Labeled EGFP in Sf9 Cells for In-Cell NMR 
 A 20-mL Sf9 suspension culture at 3.8 x 106 cells/mL in ESF 921 medium 
was infected with P3 pUltraBac-1-hsp70-AcGFP recombinant baculovirus at a 
MOI of 1 and placed into a 125-mL Erlenmeyer shake flask. Baculovirus titers 
were determined from the TCID50. Cells were incubated at 27 ° C with 150-rpm 
shaking. After 14 h, the cells were pelleted by centrifugation in the Centrific 
Model 228 centrifuge at 1,380 x g for 2 min. Pellets were resuspended in 20 mL 
of 5-FW custom algal media. Cell density and viability were determined 48 h p.i. 
with the hemocytometer and 0.4% trypan blue staining. After 48 h p.i., cells were 
pelleted by centrifugation in the Centrific Model 228 centrifuge at 1,380 x g for 2 
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min. Cells were washed with ESF 921 media and centrifuged again at 1,380 x g 
for 2 min to repellet cells. A final concentration of 10% (v/v) D2O (Cambridge 
Isotope Laboratories, Inc.) was added to the cell pellet. The cell slurry was 
pipetted into a Shigemi NMR tube (Shigemi, Inc.; Allison Park, PA). 19F spectra 
were acquired as described in 3.2.10. Cells were lysed with 1% lysis buffer and 
centrifuged in the benchtop centrifuge at 17,000 x g for 30 min. 19F spectra of the 
cleared lysate were acquired as described in 3.2.10. 
3.2.8   Sf9 EGFP Production in 15N-Enriched Custom Media 
 
15NH4Cl custom medium comprised components at the final 
concentrations shown in Table 3.5 under the heading ESF NMR medium. 
15NH4Cl was from Cambridge Isotope Laboratories, Inc. All other medium 
components, osmolality quantification, and sterile filtering are described in 3.2.4.  
In-Cell NMR 
Routinely maintained Sf9 suspension cultures in ESF 921 media were 
centrifuged in the Sorvall RC-5B centrifuge with the SS-34 rotor at 1,500 rpm for 
10 min at 25 ° C to pellet the cells. The cells were r esuspended in the 15NH4Cl 
custom medium to a final density of 2.9 x 106 cells/mL in 125-mL Erlenmeyer 
shake flasks (50-mL culture volumes). Cultures were infected with P3 pUltraBac-
1-hsp70-AcGFP recombinant baculovirus at a MOI of 1. Baculovirus titers were 
determined from the TCID50. Cells were incubated at 27 ° C with 150-rpm 
shaking. Cell density, viability, and fluorescence were determined under the 
microscope 48 h p.i. with the hemocytometer and 0.4% trypan blue staining. After 
48 h p.i., the cells were pelleted by centrifugation in the Sorvall RC-5B centrifuge 
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with the SS-34 rotor at 1,500 rpm for 10 min at 25 ° C. The cells were washed 
with PBS and pelleted again. D2O was added to attain a final D2O concentration 
of 10% (v/v), and the cell slurry was pipetted into the S500 NMR tube. HSQC 
(60) spectra were acquired as described in 3.2.10. Cells were lysed with 1% lysis 
buffer and centrifuged in the benchtop centrifuge at 17,000 x g for 30 min. HSQC 
spectra of the lysate were acquired as described in 3.2.10. 
In Vitro NMR 
Sf9 cell lysates were centrifuged in the Sorvall RC-5B centrifuge with the 
Sorvall SS-34 rotor at 16,000 rpm for 30 min at 15 ° C to remove cell debris. 
Lysates were loaded onto a Superdex 75 size exclusion column (GE Healthcare; 
Piscataway, NJ), which was equilibrated in and eluted with 20 mM sodium 
phosphate buffer, pH 6.0. Fractions were loaded onto 18% Tris-HCl SDS 
polyacrylamide gels and electrophoresed at 200 V for 50 min. Fluorescent 
fractions were pooled and concentrated by using a 3,000 molecular weight cutoff 
(MWCO) centrifugal filter unit (EMD Millipore). The EGFP concentration was 
checked by using a Nanodrop ND-1000 Spectrophotometer (Thermo Fisher 
Scientific, Inc.; Wilmington, DE). D2O was added to attain a final D2O 
concentration of 10% (v/v) for samples with and without a final concentration of 
200 mM NaCl. HSQC spectra were acquired as described in 3.2.10. 
3.2.9  Sf9 α-Syn and α-Syn-EGFP Production in 15N-Enriched Custom Media 
 The 15NH4Cl custom medium is described in 3.2.8. 15N-enriched custom 
IPL-41 media were prepared according to the chemically defined IPL-41 
formulation available from Invitrogen Corp., but without the addition of amino 
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acids (Table 3.6). Chemically Defined Lipid Concentrate, 100x (Invitrogen Corp.) 
was added to the IPL-41 media at a final concentration of 1% (v/v), and 15N-
enriched algal amino acid mix (Cambridge Isotope Laboratories, Inc.) was added 
to attain a final concentration of 1 g/L. The 15N-enriched algal amino acid mix 
lacks cysteine, tryptophan, glutamine, and asparagine. These amino acids were 
added to the custom media in unenriched form (Table 3.6). Yeastolate 
Ultrafiltrate, 50x (Invitrogen Corp.) was added to half of the prepared media at a 
final concentration of 2% (v/v). The pH values and osmolalities were adjusted to 
6.2 and 375 mOsm, respectively, and the media were sterile filtered as described 
in 3.2.4. The individual amino acids are from Sigma-Aldrich Co. The sugars are 
from Thermo Fisher Scientific, Inc. (Fair Lawn, NJ). Vitamin B12 is from MP 
Biomedicals, LLC. FeSO4·7H2O is from Allied Chemical Corp. (Morristown, NJ). 
Unless otherwise noted, the 15N-enriched custom IPL-41 media components are 
from Thermo Fisher Scientific, Inc. (Fair Lawn, NJ). 
ESF insect medium lacking L-phenylalanine, L-isoleucine, L-leucine, L-
valine, L-methionine, L-tyrosine, and L-threonine (Expression Systems, LLC) was 
used to prepare a custom NMR medium containing 15N-enriched phenylalanine. 
All seven amino acids absent from the ESF media were added at the 
concentrations present in commercial ESF 921 media (see Table 3.5 under 
15NH4Cl Custom Media). L-Phenylalanine was added in 15N-enriched form 
(Cambridge Isotope Laboratories, Inc.). The unenriched amino acids were from 
Thermo Fisher Scientific, Inc. (Fair Lawn, NJ). The pH of the medium was 
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adjusted to 6.2 followed by sterile filtering as described in 3.2.4. The osmolality of 
the medium (423 mOsm), determined as in 3.2.4, was not adjusted. 
In-Cell NMR 
Routinely maintained Sf9 suspension cultures in ESF 921 media were 
centrifuged in the Sorvall RC-5B centrifuge with the SS-34 rotor at 1,500 rpm for 
10 min at 25 ° C to pellet the cells. Cells were resuspe nded in 30 mL of 15NH4Cl 
custom medium to a final density of 5.3 x 106 cells/mL in 125-mL Erlenmeyer 
shake flasks. Cells were resuspended in 40 mL of 15N-phenylalanine custom 
medium or 15N-enriched custom IPL-41 media to final densities of 4.5 x 106 
cells/mL in 125-mL Erlenmeyer shake flasks. Two cultures in 15NH4Cl custom 
media were infected with either P3 α-syn pUltraBac-1 or P3 α-syn-EGFP 
pUltraBac-1 recombinant baculovirus at a MOI of 1. Two cultures in 15N-
phenylalanine custom media were infected with either P3 α-syn pUltraBac-1 or 
P3 α-syn-EGFP pUltraBac-1 recombinant baculovirus at the same MOI. One 
culture in 15N-enriched custom IPL-41 medium was infected with P3 α-syn-EGFP 
pUltraBac-1 recombinant baculovirus at that MOI. The cultures were incubated at 
27 ° C with 150-rpm shaking.  Cell density, viability, and fluorescence were 
determined under the microscope 43-44 h p.i. with the hemocytometer and 0.4% 
trypan blue staining. After 43-44 h p.i., the cells were pelleted by centrifugation in 
the Sorvall RC-5B centrifuge with the SS-34 rotor at 1,500 rpm for 10 min at 25 ° 
C. The supernatants were decanted, and D2O was added to the pellets to attain 
a final D2O concentration of 10% (v/v). The cell slurries were pipetted into S500 
NMR tubes, and HSQC spectra were acquired as described in 3.2.10. After 
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acquisition, cells were lysed with Triton X-100 lysis buffer (25 mM sodium 
phosphate buffer, pH 7.0, 150 mM NaCl, 1% Triton X-100) and centrifuged in the 
benchtop centrifuge at 17,000 x g for 30 min. HSQC spectra of the lysates were 
acquired as described in 3.2.10. 
3.2.10   NMR 
 
19F spectra were acquired at 37 ° C on a Varian Inova 60 0 MHz 
spectrometer (Palo Alto, CA) equipped with a 5 mm 19F {1H} z-gradient probe. 
The spectra comprised 128 to 2048 transients with a 30 kHz sweep width and a 
2 s acquisition delay. Trifluoroethanol at 0 ppm was used to reference the 19F 
chemical shifts.  
1H -15N HSQC spectra were acquired at 25 ° C on the Varian I nova 600 
MHz spectrometer equipped with a triple resonance HCN probe. The 1H 
dimension sweep width was 8401 Hz and comprised 1024 complex points. The 
15N dimension sweep width was 2200 Hz and comprised 64 complex points. The 
data were processed with NMRPipe (58) and NMRView (59). 
3.3   Results and Discussion  
3.3.1   EGFP Detection 
As proof of technique, recombinant baculovirus was generated by using 
the pFastBac Dual vector (Fig. 3.2) containing the EGFP gene. The production of 
EGFP, a fluorescent protein, provides a convenient means of detecting 
baculovirus infection (114). Infected Sf9 cells were visualized by laser scanning 
confocal microscopy (Fig. 3.3). Sf9 cells emitted green fluorescence, indicating 
production of EGFP in the cells (Fig. 3.3a, b). Although the fraction of cells 
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fluorescing green was not quantified, the majority of cells fluoresce green. The 
total cellular proteins were subjected to sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE; Fig. 3.4). No bands corresponding to EGFP 
were detected by Brilliant Blue staining (Fig. 3.4a). However, fluorescence 
imaging shows bands corresponding to EGFP in the whole cell lysates (Fig. 
3.4b). Visual confirmation of EGFP production in infected Sf9 cells provided the 
technical expertise and confidence required to attempt α-syn production, a 
protein that cannot be followed by fluorescence.  
3.3.2   α-Syn Detection 
The human wild-type α-syn gene was inserted under the control of the 
Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) polyhedrin 
(PH) promoter in the pFastBac 1 vector (Fig. 3.5). α-Syn pFastBac 1 recombinant 
baculovirus was generated and used to infect Sf9 cells in suspension culture. 
Western blot results (Fig. 3.6) show the presence of α-syn in the whole cell 
lysates.  
The estimated concentration of α-syn in 1 L of cell suspension at 2 x 106 
cells/mL 1-8 days p.i. (Table 3.7) was calculated as follows. Cell aliquots were 
pelleted and resuspended in lysis buffer to a final density of 1 x 107 cells/mL. 
Multiplication of the lysate cell density by the volume of lysate loaded onto SDS 
polyacrylamide gels yields the number of cells in each lane. The amount of α-syn 
present in the western blots was determined with the VersaDoc software by 
comparison of lysate band intensities to the intensities of known amounts of 
loaded α-syn control (1.9 µg per lane). Dividing the amount of α-syn present in 
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the lysate by the number of cells yields the amount of α-syn per cell. The amount 
of α-syn per cell was divided by the molecular weight of α-syn (14.4 kDa) to yield 
the number of moles of α-syn per cell. Multiplication of the number of moles by 2 
x 109 cells (2 x 106 cells/mL x 1000 mL) provides an estimation of the α-syn 
concentration in a 1-L Sf9 cell suspension at 2 x 106 cells/mL.  
The estimated intracellular concentration of α-syn was calculated as 
follows. The amount of α-syn in a single cell was divided by the molecular weight 
of α-syn to yield the number of moles of α-syn per cell. The average Sf9 cell 
diameter is 15 µm (89), so the volume of a single cell was calculated to be 
4/3*π(7.5 x 10-6 m)3 = 1.8 x 10-15 m3. Conversion from m3 to L yields 1.8 pL for 
the volume of a single Sf9 cell. The number of moles of α-syn per cell was 
divided by the volume of a single Sf9 cell to yield the estimated intracellular 
concentration of α-syn in Molar.  
The maximum α-syn protein concentration in the cell suspension at a cell 
density of 2 x 106 cells/mL is 3.4 ±0.2 µM, which is achieved on day 4 p.i. (Table 
3.7). It must be noted, however, that cell viability on day 4 p.i. is 57 ±3%, too low 
for in-cell NMR. Previous work shows that insect cells may be grown in 
suspension culture at 3 x 107 cells/mL while maintaining >90% viability (115). 
This higher Sf9 cell density corresponds to maximum α-syn protein 
concentrations of ~50 µM in cell suspension. Protein concentrations in the 102 
µM range, however, are required for the acquisition of high resolution NMR data 
(39, 45). Although the α-syn concentration is estimated to be too low for NMR at 
3 x 107 cells/mL, Sf9 cell densities can be increased by pelleting the cells through 
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centrifugation. Pelleting Sf9 cells from suspension culture and counting by 
hemocytometer yields 2.6 x 108 cells/mL, the maximum achievable density of Sf9 
cells. The cell pellet can be placed in the NMR tube to achieve the maximum 
concentration of α-syn for NMR experiments. Estimation of the concentration of 
α-syn in the NMR tube was determined by multiplying the estimated α-syn 
concentrations at 2 x 106 cells/mL by a factor of 130 (2.6 x 108 cells/mL / 2 x 106 
cells/mL = 130). At 4 days p.i., the maximum α-syn concentration expected in the 
NMR tube is 447 ±31 µM, which is sufficient for in-cell NMR (Table 3.7). These 
results demonstrate that the α-syn protein concentration achieved in suspension 
culture has the potential to yield acceptable concentrations for protein in-cell 
NMR when cells are pelleted and placed in the NMR tube. The next step is to 
isotopically enrich the protein. 
3.3.3   Custom Sf9 Insect Media 
Commercially available media for isotopic enrichment of recombinant 
proteins in insect cells are prohibitively expensive (Bioexpress-2000 media 15N 
98% from Cambridge Isotope Laboratories, Inc. is $7,500 per liter). As a result, 
only a single study using this media to uniformly label a recombinant protein in 
Sf9 cells has been published (116). Therefore, attempts were made to produce 
custom media by using a basal medium and adding less expensive growth 
components. Walton et al. developed a custom medium for a fraction of the cost 
of commercially available media (110). The medium utilizes a relatively cheap 
amino acid mixture derived from algae to supply most of the 15N-enriched amino 
acids. By infecting Sf9 cells in this custom medium with recombinant baculovirus 
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to produce the avian Thy-1 protein, the investigators observed 60% of the 
production level achieved by using commercial 15N insect media. Furthermore, 
80% of the anticipated resonances for Thy-1 were observed in 1H-15N HSQC 
spectra of the purified protein.  
Custom insect media were prepared by following the published protocol of 
Walton et al. (110). Custom media were initially prepared in unenriched form to 
assess cell growth and viability. The algal amino acid mix lacks four amino acids: 
glutamine, asparagine, cysteine, and tryptophan. These amino acids were added 
to the custom algal media preparations as described in 3.2.4. Custom media 
prepared by Walton et al. did not call for the addition of asparagine. As a 
precaution in this study, asparagine was included in some preparations. 15N-
glutamine is one of the most expensive amino acids, and it has been shown that 
insect cells can produce glutamine from glutamate and NH4Cl (117). Therefore, 
custom algal media were also prepared with the additions of glutamate, NH4Cl, 
asparagine, cysteine, and tryptophan as described in 3.2.4. Later, addition of 
15NH4Cl will allow isotopic enrichment of glutamine. Additionally, Cell Free amino 
acid mix, containing all 20 amino acids, was used to prepare custom media 
without the need to supplement with additional amino acids as described in 3.2.4. 
Cells were grown in custom media, and aliquots (100 µL) were removed 
about every 24 h for 6 days to determine the cell density and viability. Figures 3.7 
and 3.8 show Sf9 cell growth and viability data in custom media, respectively. Sf9 
cells in custom media grow from an initial density of 1 x 106 cells/mL to 2-3 x 106 
cells/mL after 6 days (142 h), indicating that cells undergo about 1 round of cell 
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division (Fig. 3.7). Sf9 cell viability remains greater than 80% through 5 days (117 
h) of incubation in all custom media compared to 91% in commercial ESF 921 
medium (Fig. 3.8). Although cell growth is slowed in custom media, cell viability 
remains acceptable for in-cell NMR.  
Next, suspension cultures of Sf9 cells in custom media were infected with 
α-syn pFastBac 1 recombinant baculovirus. Aliquots (100 µL) were removed 
about every 24 h p.i. for 6 days to determine cell density and viability. Aliquots (1 
mL) were removed about every 24 h p.i. for 6 days to determine α-syn 
production. Infected Sf9 cells in custom media grew from an initial density of 1 x 
106 cells/mL to 1.5-3 x 106 cells/mL 6 days (140 h) p.i. (Fig. 3.9a). Cell viability 
remained ≥76% 3 days (68 h) p.i. in custom media (Fig. 3.9b).  
Western blots of whole cell lysates detected virtually no α-syn (data not 
shown). α-Syn production may have been low due to the unknown α-syn 
baculovirus titer or a sugar or yeastolate limitation in the media. Custom medium 
was prepared with larger amounts of yeastolate and glucose. Sf9 cells were 
infected in this new custom medium (see 3.2.4) at a MOI of 3 with α-syn 
pFastBac 1 recombinant baculovirus of known titer. However, western blots of 
whole cell lysates from 72 h and 96 h p.i. show that almost no α-syn (Fig. 3.10) 
was produced. The estimated α-syn concentration is 0.1 µM 96 h p.i. at a cell 
density of 2 x 106 cells/mL. This level of α-syn production is insufficient for in-cell 
NMR even when pelleting the cells into the NMR tube (2.6 x 108 cells/mL, 13 µM 
α-syn). Furthermore, cell viability after just 72 h p.i. is 55%, unacceptable for in-
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cell NMR. These results demonstrate that Sf9 production of α-syn by baculovirus 
infection is insufficient for in-cell NMR using the developed custom media. 
3.3.4   InsectDirect 
 After the unsuccessful attempts to produce sufficient α-syn and maintain 
viability in infected Sf9 cells for in-cell NMR, another expression system was 
employed. The InsectDirect system (EMD Biosciences, Inc.; Madison, WI) 
produces high levels of recombinant protein without the need to create a 
recombinant baculovirus (118). Results from the company show that 8 mg of 
HSP27 was produced in a 100-mL Sf9 suspension culture (118). This production 
level corresponds to a HSP27 concentration of 30 µM, enough for in-cell NMR 
when pelleting the cells into the NMR tube (calculated as described in 3.3.2 using 
27 kDa as the molecular weight of HSP27). The InsectDirect vectors employ a 
homologous region 5 (hr5) enhancer and immediate early 1 (IE1) promoter 
combination to recruit endogenous insect cell transcription machinery to directly 
produce the protein of interest (119). This shortcut avoids the cytotoxic effects of 
baculovirus infection. Additionally, the vectors facilitate ligation-independent 
cloning (LIC) to insert the desired genes (120), enabling quick screening of 
multiple target genes. The system is also fast; vector construction to protein 
production can be accomplished in one week.  
 The rapid generation of vectors and quick turnaround to protein production 
allowed the testing of several target genes. The cytochrome c, α-syn, AcGFP, 
ubiquitin, and HSP27 genes were cloned into InsectDirect pIEx-7 Ek/LIC vectors 
(Fig. 3.11) and purified to µg quantities. The recombinant pIEx-7 vectors were 
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transfected into Sf9 cells in suspension, and the cultures were harvested after 48 
h for recombinant protein purification. The pIEx-7 Ek/LIC vector encodes a 
histidine tag (His-tag) at the N-terminus of the protein of interest, allowing easy 
purification using the Insect Robopop Ni-NTA His-Bind Purification Kit. 
 Protein yields were determined by using the Lowry assay (121). All 
recombinant proteins are detectable by this method, but the estimated yields are 
too low for in-cell NMR (Table 3.8). AcGFP and HSP27 are the two highest 
yielding proteins at 1.5 mg/L (0.06 µM) and 2.7 mg/L (0.10 µM) at 2 x 106 
cells/mL, respectively, and are detectable by SDS-PAGE (Figures 3.12 and 
3.13). However, α-syn, cytochrome c, and ubiquitin were not detected by SDS-
PAGE with Brilliant Blue staining. Gel results show that the major HSP27 product 
is an aggregated form that runs around 60 kDa (Fig. 3.12), too large for in-cell 
NMR detection with the 1H-15N HSQC experiment (122, 123). AcGFP was 
detectable by fluorescence (Fig. 3.13b) and ran on the gel at 27 kDa, but a non-
fluorescent higher molecular weight band was also present (Fig. 3.13a). Since 
recombinant protein concentrations in the 102 µM range are required for in-cell 
NMR, AcGFP and HSP27 yields are not sufficient for in-cell NMR even when Sf9 
cells are maximally compacted into a NMR tube (8 µM for AcGFP and 13 µM for 
HSP27, calculated as described in 3.3.2 using 27 kDa as the molecular weight 
for both proteins). Furthermore, transfected Sf9 cell viabilities after 48 h were 
<50% (Table 3.8), unsuitable for in-cell NMR, compared to 81% for mock infected 
cells. These results show that the InsectDirect system neither produced sufficient 
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quantities of recombinant protein nor sustained cell viability for in-cell NMR 
experiments.  
3.3.5   Drosophila S2 Cell Infection 
 Since attempts to produce sufficient levels of recombinant protein and 
maintain cell viability for in-cell NMR were unsuccessful, an alternative strategy 
was employed. Baculoviruses are capable of infecting not only lepidopteran cells 
but also nonnative host cells (124-130). To drive production of the protein of 
interest, the virus is modified to contain a promoter that is active in the nonnative 
host cell (131). Because the baculovirus is present in a nonnative host cell, the 
virus is incapable of replicating, and thus the cytotoxic effects and cell lysis 
associated with baculovirus infection are avoided.  
 Drosophila S2 cells were selected as the nonnative host for a modified 
recombinant baculovirus because these cells grow under conditions similar to 
those used for Sf9 cells (room temperature ambient air conditions), and these 
cells are relatively easy to culture (132). Lee et al. showed infection of Drosophila 
S2 cells with a recombinant baculovirus containing EGFP under the control of the 
Drosophila heat shock protein 70 (hsp70) promoter produced 3.2 mg/L of EGFP 
at 8 x 106 cells/mL and maintained 93% cell viability 72 h p.i. (130). S2 cells 
occupy about one-fifth the volume of Sf9 cells (130), so it is expected that the 
cells could be placed in a NMR tube at densities of ~10 x 108 S2 cells/mL 
(maximum Sf9 density is 2.6 x 108 cells/mL). These S2 cell densities yield an 
estimated EGFP concentration of 400 µM, which is suitable for in-cell NMR.   
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A strategy to produce AcGFP in S2 cells was developed by using the 
hsp70 promoter to drive production of AcGFP in recombinant baculovirus 
infected S2 cells (130, 133). The AcGFP gene from the pAcGFP1 vector was 
cloned into the MCS of the pUAST vector (Fig. 3.14) under the control of the 
hsp70 promoter. The hsp70-AcGFP cassette was excised by restriction enzyme 
digestion and cloned into the pUltraBac-1 vector (Fig. 3.15). The pUltraBac-1 
vector is a modified version of pFastBac Dual where the p10 promoter has been 
replaced with the late basic protein promoter (PBasic) and the EGFP gene, under 
the control of PBasic (133). EGFP production occurs sooner under PBasic  than p10 
control, allowing faster titer determination when amplifying the recombinant 
baculovirus in Sf9 insect cells. HindIII and BamHI restriction sites were added to 
the pUltraBac-1 vector upstream of the PH promoter and downstream of the PH 
promoter MCS, respectively. In the modified vector, restriction enzyme digestion 
removes the lepidopteran specific PH promoter and replaces it with the S2 host 
specific hsp70 promoter-AcGFP cassette. 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus generation was 
performed in a similar manner to that described in 3.2.2 except that the P2 stock 
was used to infect a total culture volume of 250 mL to generate large amounts of 
P3 recombinant baculovirus. Because baculoviruses are incapable of replicating 
in nonnative host cells, recombinant protein production is based on the number 
of viral particles in each cell upon initial infection. Thus, it is important to infect S2 
cells at a high MOI (e.g. 100) to produce high yields of recombinant protein (130). 
The P3 baculovirus was concentrated from the culture media by centrifugation at 
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high speeds as has been previously reported (133). The P3 stock titer was 5.85 x 
109 pfu/mL, in the range expected from this concentration method.  
S2 cells were seeded in 24-well tissue culture plates and infected at 
varying MOIs up to 200 with P3 pUltraBac-1-hsp70-AcGFP recombinant 
baculovirus. Cell viability was confirmed to be 95% by trypan blue staining prior 
to infection. After 36 h, cells were inspected under the microscope. Cell viability 
appeared low due to the shriveled shape of most of the cells, and no cells 
fluoresced green. No AcGFP was detected in fluorescence scans and with 
Brilliant Blue staining of SDS gels containing S2 whole cell lysates. Lack of 
AcGFP production appears to be tied to the low viability of S2 cells upon infection 
with recombinant baculovirus at high MOIs. These results are not consistent with 
reports showing that baculovirus infection of S2 cells has little negative effect on 
S2 cell viability (130).  
3.3.6   EGFP Production in Sf9 Cells with pUltraBac-1-hsp70-AcGFP 
 Production of the reporter EGFP protein under PBasic promoter control 
appeared to be high during baculovirus amplification of pUltraBac-1-hsp70-
AcGFP in Sf9 insect cells due to the large number of fluorescent cells observed 
under the microscope (data not shown). To quantify EGFP production levels, Sf9 
cells were infected with P3 pUltraBac-1-hsp70-AcGFP baculovirus at a MOI of 1 
in commercial ESF 921 media. Cells were harvested 48 h and 72 h p.i., lysed, 
and electrophoresed on a SDS gel to detect fluorescence (Fig. 3.16). 
Examination of cells 48 h and 72 h p.i. revealed that nearly all cells fluoresce 
green 48 h p.i. Initial cell viability was 96% prior to infection, 85% 48 h p.i., and 
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54% 72 h p.i. (Table 3.9). Quantification of EGFP fluorescence from Sf9 whole 
cell lysates 48 h and 72 h p.i. shows that the EGFP concentration is 2.1 µM and 
2.2 µM at 2 x 106 cells/mL, respectively (Table 3.9). Thus, EGFP production 
reaches its maximum 48 h p.i. when cell viability is still acceptable for in-cell 
NMR. EGFP concentration 48 h p.i. is estimated to be 278 µM when cells are 
pelleted to 2.6 x 108 cells/mL in the NMR tube. This EGFP concentration is 
sufficient for in-cell NMR. Calculations were performed as described in 3.3.2 
using 27 kDa as the molecular weight of EGFP.  
The pUltraBac-1 vector contains the EGFP gene under the control of the 
lepidopteran active PBasic promoter to allow faster titering of recombinant 
baculoviruses in Sf9 insect cells (133). The PBasic promoter produces 
recombinant proteins at earlier times (12 h p.i.) than the frequently used PH 
promoter (18 h p.i. or later), and protein production levels are comparable 
between the promoters (134). Earlier production of recombinant protein by the 
PBasic promoter is advantageous for in-cell NMR because maximum protein 
production takes place before the cytotoxic effects associated with baculovirus 
infection reduce cell viability.  
EGFP production and Sf9 cell viability upon pUltraBac-1-hsp70-AcGFP 
recombinant baculovirus infection were assessed by using custom media to 
reduce the cost of isotopic enrichment for NMR as discussed in 3.3.3. Sf9 cells 
were infected at a MOI of 1 in commercial ESF 921 media, custom algal media, 
20 A.A. media, and the two custom media supplemented with 5% ESF 921 
media. The 5% ESF 921 media were added to stimulate cell growth. Samples 
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were collected to determine cell density and viability and lysed for fluorescence 
detection on SDS gels 48 h and 72 h p.i. (Fig. 3.17). Nearly all cells fluoresce 
green 48 h p.i. under the microscope, and cells appear healthy as noted by their 
round shape and lack of cell debris. Cell viabilities were ≥89% in custom media 
48 h p.i. as assessed by trypan blue staining (Table 3.10). EGFP concentrations 
48 h and 72 h p.i. were determined as described in 3.3.2 using the fluorescence 
results (Fig. 3.17) and 27 kDa as the molecular weight of EGFP. At 2.6 x 108 
cells/mL, the estimated maximum Sf9 cell density in the NMR tube, the EGFP 
concentrations are ≥185 µM in all custom media 48 h p.i. (Table 3.10). These 
EGFP concentrations are sufficient for protein in-cell NMR. Furthermore, 
maximum EGFP production is achieved 48 h p.i. in custom media when cell 
viability remains ≥89% (Table 3.10). EGFP production in algal and 20 A.A. 
custom media is nearly as high as production in commercial ESF 921 media. It is 
evident that the early protein production conferred by the PBasic promoter provides 
an advantage for in-cell NMR; waiting until 72 h p.i. before collecting cells yields 
cell viabilities ≤61% in custom media, unacceptable for in-cell NMR (Table 3.10). 
These results are also more favorable than those obtained with the α-syn 
pFastBac 1 recombinant baculovirus where the α-syn gene is under the PH 
promoter. In that system, maximum α-syn production was not observed until 
about day 4 p.i. when cell viability was 57% (Table 3.7), unacceptable for in-cell 
NMR.   
Sf9 cell viability in the NMR tube was assessed to determine the feasibility 
of performing in-cell NMR experiments. Sf9 suspension cultures were centrifuged 
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to pellet the cells, and the cells were pipetted into a NMR tube. The NMR tube 
was left at room temperature, and cell aliquots (100 µL) were removed after 3 h, 
6 h, 21 h, and 25 h to determine cell viability. Initial Sf9 cell viability was nearly 
100% and was measured to be 93%, 90%, 84%, and 13% after 3 h, 6 h, 21 h, 
and 25 h, respectively. These results demonstrate that Sf9 cell viability inside the 
NMR tube remains acceptable for in-cell NMR experiments for at least 6 h. 
5-Fluorotryptophan (5-FW) was selected as the means to label EGFP with 
a NMR active nucleus. 5-FW is relatively inexpensive, and 19F labeling should 
provide better sensitivity than 15N enrichment (70). Labeling sites, however, are 
limited to tryptophan residues only. EGFP contains one tryptophan at position 57, 
and in vitro EGFP 19F NMR data from protein produced in E. coli are available 
(135). Additionally, studies show that 5-FW incorporation does not affect protein 
structure (136). Sf9 cell viability experiments were performed to assess whether 
5-FW containing media had a deleterious effect on Sf9 cell growth and viability. 
Sf9 suspensions in commercial ESF 921 media were pelleted by centrifugation 
and resuspended in 5-FW custom algal media. Trypan blue staining showed Sf9 
cell viability remained high (97%) after 48 h of incubation. Next, EGFP production 
was tested in Sf9 infected cells using 5-FW custom algal media. Cell viability and 
EGFP concentrations were assessed 24 h, 48 h, and 72 h p.i. (Table 3.11). 
EGFP concentrations were determined as described in 3.3.2 using 27 kDa as the 
molecular weight of EGFP. Results show 48 h p.i. an estimated EGFP 
concentration of 183 µM at 2.6 x 108 cells/mL, high enough for in-cell NMR. 
Additionally, cell viability is 87% 48 h p.i., acceptable for in-cell NMR. These 
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results are similar to those obtained from infected Sf9 cells 48 h p.i. in custom 
algal media containing tryptophan (228 µM and 89% viability, Table 3.10) 
indicating that 5-FW exerts no harmful effects on cell viability or protein 
production.  
 Sf9 EGFP production in 5-FW custom algal media and viability in the NMR 
tube is acceptable for in-cell NMR experiments. A Sf9 cell infection using P3 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus was performed in 
commercial ESF 921 media. After 14 h, the suspension culture was centrifuged, 
and the Sf9 cell pellet was resuspended in 5-FW custom algal media. Switching 
to labeling media was done 14 h p.i. when EGFP production by the PBasic 
promoter is maximized, a strategy expected to reduce background labeling of 
other proteins and metabolites (137). Cells were pelleted by centrifugation 48 h 
p.i., when sufficient EGFP for in-cell NMR is expected, and placed in a NMR tube 
for 19F NMR acquisition of the cell slurry. Cell viability, as assessed by trypan 
blue staining, was 89% 48 h p.i. and nearly all cells fluoresced green under the 
microscope, indicating production of EGFP. The 19F spectrum of the cell slurry 
shows a single resonance (Fig. 3.18a). NMR acquisition of the cleared cell lysate 
shows the same resonance (Fig. 3.18b). Comparison to the 19F spectrum of 5-
FW alone (data not shown) reveals that the cell slurry and lysate resonances are 
from 5-FW.  
As EGFP production appears to be sufficient (cells fluoresce green), 
absence of protein 19F resonances may be due to the lack of 5-FW incorporation 
into EGFP by the Sf9 cells. The 5-FW custom algal medium was checked for 
104 
 
sources of natural tryptophan. Yeastolate, an undefined mixture of amino acids, 
peptides, sugars, vitamins, and minerals is often added to insect cell media to 
promote growth (138, 139). Yeastolate may be a source of tryptophan. 
Therefore, 5-FW custom algal media were prepared without yeastolate. The 
EGFP concentration is estimated to be 190 µM 48 h p.i. at 2.6 x 108 cells/mL for 
Sf9 cells infected in custom algal media containing 0% yeastolate, and the cells 
remain 87% viable (Table 3.12). Addition of yeastolate to the media did not 
increase the production of EGFP (Table 3.12). Thus, yeastolate is not required 
for cell growth and EGFP production in infected Sf9 cells.  
A control experiment was performed in unlabeled custom algal media 
without dialyzed yeastolate and tryptophan to remove all sources of tryptophan. 
Sf9 cells were infected with pUltraBac-1-hsp70-AcGFP recombinant baculovirus 
in this custom medium lacking yeastolate and tryptophan. It was anticipated that 
cells would be unable to grow or produce proteins, including EGFP, because Sf9 
cells cannot synthesize tryptophan (140). Results show that the EGFP 
concentration is 215 µM at 2.6 x 108 cells/mL and Sf9 cells are 96% viable 48 h 
p.i. in custom algal media containing no yeastolate and no tryptophan (Table 
3.13). The production of EGFP is only slightly reduced from that of Sf9 infected 
cells grown in the presence of tryptophan (270 µM 48 h p.i. at 2.6 x 108 cells/mL). 
Additionally, nearly all Sf9 cells fluoresced green in custom media without 
tryptophan when viewed 48 h p.i. under the microscope. The results show that 
infected Sf9 cells produce EGFP in the absence of tryptophan. 
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A final attempt was made to control sources of tryptophan in the custom 
media. Rather than using the algal amino acid mix as the source of amino acids, 
custom media were prepared where each amino acid except tryptophan was 
added from separate sources (Table 3.5). There should be no source of 
tryptophan is this medium. Media were prepared with all 20 amino acids, 19 
amino acids (no tryptophan), and without addition of any amino acids. Sf9 cells 
were infected with pUltraBac-1-hsp70-AcGFP recombinant baculovirus in these 
custom media. The data in Table 3.14 show that Sf9 cell viability remains high 48 
h p.i. even in the absence of any amino acid source (≥82%). EGFP production 
was not quantified. However, the majority of cells grown in 20 individual A.A. and 
19 individual A.A. media fluoresced green 72 h p.i. and about 50% of cells grown 
in media lacking amino acids fluoresced green 72 h p.i. as assessed under the 
microscope. These results demonstrate that infected Sf9 cells are able to 
maintain cell viability for at least 48 h and produce recombinant proteins in media 
lacking tryptophan or any amino acids. Since Sf9 cells are able to obtain 
tryptophan by some unknown means, it is unlikely that the cells would utilize the 
unnatural 5-FW provided in the custom media for EGFP production. Thus, 
protein in-cell NMR with 5-FW labeling is not possible in Sf9 insect cells under 
these conditions. 
3.3.7   Sf9 EGFP Production in 15N-Enriched Custom Media 
It is possible that Sf9 cells did not utilize 5-FW because it is an unnatural 
amino acid. An alternative strategy for isotopic enrichment in Sf9 cells may be 
the use of 15N-containing amino acids or other 15N compounds because these 
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components differ from their natural counterparts by just one atomic mass unit. 
Use of 15NH4Cl as a source of 15N amino acids for enriching overproduced 
proteins in Sf9 cells is attractive due to its low cost. It is known that Sf9 cells can 
adapt to and grow in media supplemented with NH4Cl at concentrations up to 
about 15 mM (110, 141). Sf9 cells incorporate nitrogen from NH4Cl into glutamic 
acid and alanine backbone amides and glutamine and asparagine side chain 
amides (110).     
15NH4Cl custom medium was prepared as shown in Table 3.5. 15NH4Cl 
was added to a final concentration of 15 mM. Individual amino acids were added 
to the medium to mimic the amino acid composition of commercial ESF 921 
media (113) rather than the algal amino acid mix used previously. Glutamine was 
omitted and additional glutamate was added because Sf9 cells can synthesize 
glutamine from NH4Cl and glutamate (117). 
Sf9 cells were infected with pUltraBac-1-hsp70-AcGFP recombinant 
baculovirus in 15NH4Cl custom medium. Cell viability prior to infection was 97% 
and remained high 48 h p.i. (96%). Forty percent of Sf9 cells fluoresced green 48 
h p.i. The lower fraction of green fluorescing cells 48 h p.i. compared to results in 
custom media without NH4Cl may be due to a reduction of EGFP production 
caused by NH4Cl inhibition of baculovirus infection (110). The HSQC spectrum of 
the cell slurry shows just three crosspeaks, two of which appear in the protein 
side chain amide region (Fig. 3.19a). These results show 15N enrichment of one 
or more cellular proteins, but cannot be definitively attributed to EGFP. Sf9 
lysates prepared 96 h p.i. show a similar crosspeak pattern (Fig. 3.19b). EGFP 
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was purified by size exclusion chromatography (Fig. 3.20) and concentrated for 
use in in vitro HSQC acquisition. The total protein concentration in the pooled 
fractions containing EGFP was 420 µM. This in vitro EGFP sample was used to 
acquire a HSQC spectrum (Fig. 3.21a). Only two crosspeaks associated with 
protein side chain amides were observed. These results show 15N incorporation 
into one or more proteins. Loss of the single crosspeak from the spectrum of the 
cell slurry, associated potentially with a protein amide backbone nitrogen, 
suggests that the enriched protein in the in vitro sample had aggregated. The two 
crosspeaks associated with protein side chain amides might still be present in an 
aggregated form of the protein because the side chains have greater mobility 
(52). A review of the literature revealed that GFP forms dimers at concentrations 
≥100 µM (142). These dimers are too large to detect by HSQC NMR. Adding 
NaCl, however, may break up the hydrophilic contacts stabilizing the dimer. A 
spectrum of the purified EGFP in 200 mM NaCl was acquired (Fig. 3.21b). The 
spectrum, however, still only contains the two amide side chain crosspeaks.  
 It cannot be definitively stated that EGFP was 15N-enriched in Sf9 cells 
because in vitro spectra were inconclusive, perhaps due to EGFP dimerization or 
aggregation. However, Sf9 cells appear to have incorporated 15N into proteins 
through 15NH4Cl in the custom media. Thus, the possibility to 15N enrich other 
recombinant proteins exists. The production of an intrinsically disordered protein 
such as α-syn in Sf9 cells using 15NH4Cl custom media may allow the acquisition 
of in-cell HSQC spectra because intrinsically disordered proteins are easier to 
detect than globular proteins in cells (49).  
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3.3.8  Sf9 α-Syn and α-Syn-EGFP Production in 15N-Enriched Custom Media 
Detection of protein amide side chain crosspeaks in the cell slurry, lysate, 
and in vitro HSQC spectra of Sf9 cells infected with pUltraBac-1-hsp70-AcGFP 
recombinant baculovirus suggests that 15N enrichment of EGFP may have 
occurred. However, the globular structure of EGFP prevents detection of the 
protein backbone crosspeaks by HSQC NMR (69). Furthermore, EGFP dimers 
(142) or higher order aggregates may have formed in the purified sample, 
preventing attempts to detect the protein backbone crosspeaks by in vitro HSQC 
NMR. It was hypothesized that 15N enrichment of an intrinsically disordered 
recombinant protein in Sf9 cells would allow detection of the protein’s backbone 
crosspeaks by in-cell HSQC NMR because disordered proteins are detectable in 
cells (49). The intrinsically disordered protein α-synuclein was selected due to 
prior experience successfully producing the recombinant protein in Sf9 cells. 
The α-syn gene was cloned into the pUltraBac-1 vector under the control 
of the PBasic promoter. Two constructs were created, one containing α-syn and 
another containing both the α-syn and EGFP genes to generate a fusion protein. 
The rationale in creating the fusion construct was to allow fluorescence 
visualization of Sf9 cell infection. To generate the α-syn pUltraBac-1 vector, the 
EGFP gene under PBasic control was removed from the pUltraBac-1 vector by 
restriction enzyme digestion to allow insertion of the α-syn gene under PBasic. To 
generate the α-syn-EGFP pUltraBac-1 vector, the α-syn gene was amplified with 
primers designed to remove the stop codon and maintain the reading frame for 
EGFP. The pUltraBac-1 vector was then digested with a single restriction 
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enzyme at the multiple cloning site downstream of the PBasic promoter to allow 
insertion of the α-syn gene. The resulting construct under PBasic control contained 
the α-syn gene followed by the EGFP gene. The two genes were separated by a 
nine nucleotide linker sequence (5’ TCTCGAGCC 3’) predicted to produce the 
peptide α-syn-Ser-Arg-Ala-EGFP. DNA sequence analysis of the completed 
vector revealed that the linker sequence is 5’ TCTCGAGGG 3’ resulting in a 
linker region comprising Ser-Arg-Gly. The discrepancy probably arises from 
inaccuracies in the pUltraBac-1 sequencing data.   
Initial Sf9 infection experiments were performed with α-syn pUltraBac-1 
and α-syn-EGFP pUltraBac-1 recombinant baculoviruses to quantify production 
levels of the recombinant proteins in commercial ESF 921 media. Inspection of 
cells 48 h and 72 h p.i. under the microscope showed evidence of infection and 
acceptable viability through 48 h p.i. (Table 3.15). Under the microscope, 90% of 
Sf9 cells infected with the α-syn-EGFP pUltraBac-1 recombinant baculovirus 
fluoresced green 48 h p.i., indicating successful infection. Sf9 cells infected with 
α-syn pUltraBac-1 recombinant baculovirus did not fluoresce green as expected, 
but it was assumed that the cells were infected because both infections were 
performed in parallel. Additionally, enlargement of most of the cells inoculated 
with the α-syn pUltraBac-1 recombinant baculovirus suggested infection had 
occurred. Importantly for in-cell NMR, Sf9 cell viability 48 h p.i. was ≥90% for Sf9 
cells infected with α-syn pUltraBac-1 and α-syn-EGFP pUltraBac-1 recombinant 
baculoviruses (Table 3.15).  
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Cell aliquots were collected 48 h and 72 h p.i. and the cellular proteins 
separated by SDS-PAGE. EGFP was detected by fluorescence, and α-syn was 
detected by western blotting. Fluorescence was observed at the molecular 
weight corresponding to EGFP (27 kDa) and at a higher molecular weight in the 
lanes corresponding to Sf9 cells infected with α-syn-EGFP pUltraBac-1 
recombinant baculovirus (Fig. 3.22a). The fluorescence of the higher molecular 
weight species is more intense than that of the lower molecular weight band. 
Thus, the higher molecular weight species is interpreted as the primary 
recombinant α-syn-EGFP fusion protein, and the lower molecular weight species 
appears to be a degradation product, most likely free EGFP. 
Quantification of EGFP fluorescence 48 h and 72 h p.i. yields an 
estimated intracellular α-syn-EGFP concentration of 5000 µM and 5080 µM, 
respectively (Table 3.15). Thus, EGFP production reaches its maximum 48 h p.i. 
when cell viability is still acceptable for in-cell NMR (94%).The α-syn-EGFP 
concentration is estimated to be 2340 µM when pelleting the cells into the NMR 
tube 48 h p.i. This α-syn-EGFP concentration is sufficient for in-cell NMR.  
Detection of α-syn by western blotting corroborates the fluorescence data. 
The lanes corresponding to cells infected with α-syn-EGFP pUltraBac-1 
recombinant baculovirus display multiple bands running at higher molecular 
weights than the corresponding α-syn control (Fig. 3.22b). The highest running 
and most intense band is interpreted as the α-syn-EGFP fusion protein. The 
lower molecular weight bands are assumed to be degradation products 
containing the α-syn epitope of the antibody. The α-syn-EGFP intracellular and 
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2.6 x 108 cells/mL concentrations 48 h p.i. are estimated to be 3970 µM and 1860 
µM, respectively (Table 3.15), sufficient for in-cell NMR and in close agreement 
with estimates from fluorescence detection.  
Western blot results also show the presence of α-syn in the lysates of cells 
infected with α-syn pUltraBac-1 recombinant baculovirus (Fig. 3.22b). Lanes 
corresponding to cells infected with α-syn pUltraBac-1 recombinant baculovirus 
display bands running at the molecular weight corresponding to the α-syn control 
(~20 kDa). Quantification of α-syn 48 h and 72 h p.i. yields estimated intracellular 
concentrations of 1210 µM and 916 µM, respectively (Table 3.15). Cell viability 
remains 90% 48 h p.i. The estimated α-syn concentration at 2.6 x 108 cells/mL 48 
h p.i. is 565 µM (Table 3.15), sufficient for in-cell NMR.  
These results demonstrate that the α-syn pUltraBac-1 and α-syn-EGFP 
pUltraBac-1 recombinant baculoviruses were successfully generated for the 
production of α-syn and α-syn-EGFP in Sf9 cells. Quantification of band 
intensities yields estimated α-syn and α-syn-EGFP concentrations sufficient for 
in-cell NMR experiments. Furthermore, α-syn and α-syn-EGFP levels are similar 
48 h and 72 h p.i. (Fig. 3.22), indicating that cells can be harvested 48 h p.i. for 
in-cell NMR experiments when cell viabilities are ≥90% (Table 3.15). The next 
step is to isotopically enrich the proteins with 15N. 
Sf9 cells were infected in 15NH4Cl custom medium with α-syn pUltraBac-1 
or α-syn-EGFP pUltraBac-1 recombinant baculoviruses to isotopically enrich 
recombinant α-syn and α-syn-EGFP. Cell viability prior to infection was 99% and 
remained high at 96% upon harvesting the cells 43 h p.i. (Table 3.16). Only 24% 
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of cells infected with α-syn-EGFP pUltraBac-1 recombinant baculovirus 
fluoresced green 43 h p.i. as assessed under the microscope. The low 
percentage of green fluorescing cells, due to inhibition of baculovirus infection by 
NH4Cl (110), is consistent with prior observations of infected Sf9 cells producing 
EGFP in the same media (see 3.3.7).  
The HSQC spectra of the cell slurries producing α-syn or α-syn-EGFP 
show the same three-crosspeak pattern (Fig. 3.23a, c). Two of the crosspeaks 
correspond to the protein side chain amide region. The third crosspeak may be 
from the backbone of the recombinant proteins. This broad crosspeak becomes 
two sharper crosspeaks in the spectra of the cell lysates (Fig. 3.23b, d). 
However, α-syn contains six glutamines and three asparagines, so at least nine 
protein backbone crosspeaks are expected. Furthermore, the α-syn and α-syn-
EGFP cell slurry spectra are nearly identical to the EGFP cell slurry spectrum 
(Fig. 3.19). The similarity of the cell slurry spectra for three different recombinant 
proteins suggests that the signals arise from the enrichment of intracellular 
metabolites. The inability of Sf9 cells to utilize 15NH4Cl for uniform enrichment of 
recombinant proteins and the inhibiting effects of NH4Cl on baculovirus infection 
prompted the search for a new custom media formulated without NH4Cl to 
uniformly enrich recombinant proteins. 
Limitations in the availability of ESF NMR media without amino acids 
prompted the search for other insect media suitable for in-cell NMR. Absence of 
amino acids in the media was required so that they could be added into the 
media in 15N-enriched form. The search for commercially available media was 
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halted when the formulation of a chemically defined Sf9 medium was discovered. 
The composition of this medium, known as IPL-41, has been available for several 
decades and supports normal growth and recombinant protein production in Sf9 
cells (143, 144). The formulation comprises amino acids, vitamins, inorganic 
salts, sugars, and other organic compounds. A chemically defined mixture of 
lipids is added to provide additional components required for growth and 
protection from shear stress while in suspension culture. Finally, yeastolate is 
often added to provide additional growth factors. The chemically defined IPL-41 
formulation recipe available from Invitrogen Corp. was used as the basis for the 
custom IPL-41 NMR media (Table 3.6). Amino acids were provided in 15N-
enriched form by the addition of 15N-enriched algal amino acid mix. The algal 
amino acid mix lacks tryptophan, cysteine, asparagine, and glutamine, so these 
amino acids were added to the custom media in unenriched form. The lipid 
mixture was added to the media, and yeastolate was also added to half of the 
media. Yeastolate promotes Sf9 cell growth but contains amino acids, so it was 
not added to all of the custom IPL-41 NMR media in the event that its inclusion 
prevented 15N enrichment of the recombinant proteins. 
Sf9 suspension cultures were pelleted and resuspended in 15N-enriched 
custom IPL-41 media with or without yeastolate. The cultures were infected with 
α-syn-EGFP pUltraBac-1 recombinant baculovirus and incubated for 44 h. Cell 
viabilities were ≥94% for both samples prior to infection and remained ≥90% 44 h 
p.i. (Table 3.16). The percentage of Sf9 cells fluorescing green was not 
quantified, but nearly all cells fluoresced green as observed under the 
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microscope. The near 100% fluorescence suggests that NH4Cl inhibited 
baculovirus infection in the previous experiment. Production levels of α-syn-
EGFP were not determined by SDS-PAGE but assumed to be sufficient for in-cell 
NMR experiments due to the near uniform fluorescence observed and previous 
infection experiments in custom media (Table 3.10). The HSQC spectrum of the 
Sf9 cell slurry infected with α-syn-EGFP pUltraBac-1 recombinant baculovirus in 
15N-enriched custom IPL-41 media without yeastolate displays a similar three-
crosspeak pattern observed in all other 15N enrichment experiments (Fig. 3.24a; 
compare to Fig. 3.19 and Fig. 3.23). A few additional crosspeaks are present in 
the spectrum of the cell slurry, but not as many as expected for near uniformly 
labeled recombinant α-syn-EGFP (140 A.A. - 5 Pro - 3 Asn - 6 Gln - 0 Cys - 0 Trp 
= 126 backbone crosspeaks expected for α-syn). The spectrum of the cell lysate 
displays a similar crosspeak pattern (Fig. 3.24b). The similarities of these spectra 
to previous 15N enrichment experiments points again to 15N enrichment of 
intracellular metabolites and not the recombinant proteins of interest.  
Another 15N enrichment experiment in custom ESF media was performed 
concurrently with the experiments in 15N-enriched custom IPL-41 media. 
Although ESF NMR media without amino acids is no longer available from the 
manufacturer, an alternative medium is available. This ESF medium lacks 
phenylalanine, isoleucine, leucine, valine, methionine, tyrosine, and threonine. 
Using this ESF medium, 15N-phenylalanine custom medium was prepared by 
adding 15N-phenylalanine and the remaining six amino acids in unenriched form 
(see 3.2.9). Infection of Sf9 cells in this custom medium was rationalized as a 
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simple method to determine 15N enrichment of recombinant proteins through 15N-
phenylalanine protein backbone detection by NMR.  
Sf9 suspension cultures in 15N-phenylalanine custom media were infected 
with α-syn pUltraBac-1 or α-syn-EGFP pUltraBac-1 recombinant baculoviruses 
and incubated for 44 h. Viabilities of cultures infected with either baculovirus 
were ≥98% 44 h p.i. (Table 3.16). Nearly all cells fluoresced green in the α-syn-
EGFP pUltraBac-1 recombinant baculovirus infected culture as observed under 
the microscope. Production levels of α-syn and α-syn-EGFP were not determined 
by SDS-PAGE but assumed to be sufficient for in-cell NMR experiments based 
on previous results. The HSQC spectrum of the Sf9 cell slurry infected with α-syn 
pUltraBac-1 recombinant baculovirus and acquired 44 h p.i. displays two 
crosspeaks in the protein amide side chain region and several crosspeaks that 
could be from protein backbone amides (Fig. 3.25). However, α-syn contains just 
two phenylalanines, so only two crosspeaks are expected in the spectrum of the 
cell slurry. The spectrum of the Sf9 cell slurry infected with α-syn-EGFP 
pUltraBac-1 recombinant baculovirus and both lysate spectra were not acquired. 
The greater than expected number of crosspeaks and apparent enrichment of 
asparagine and glutamine side chain amides renders the 15N-phenylalanine 
enrichment experiments difficult to interpret. It appears that Sf9 cells incorporate 
15N-phenylalanine and its breakdown products into other amino acids and 
metabolites. Identification of crosspeaks associated with α-syn becomes difficult 
with the high degree of background enrichment. Thus, under the current 
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experimental conditions, it is not possible to acquire Sf9 in-cell HSQC spectra of 
15N-enriched disordered recombinant proteins.  
3.4   Conclusions 
 The baculovirus expression system was successfully utilized to produce 
sufficient quantities of recombinant proteins while maintaining cell viability for in-
cell NMR experiments. Results show that Sf9 cell infection with recombinant 
baculovirus containing a PBasic promoter produces sufficient EGFP for in-cell 
NMR. The PBasic promoter produces high levels of EGFP at earlier times (prior to 
cell lysis) than the more commonly used PH promoter, and thus cell viability 
remains acceptable for in-cell NMR. However, in-cell 19F NMR studies proved 
unsuccessful due to the lack of 19F incorporation into EGFP in the form of 5-FW. 
Sf9 cells can metabolize NH4Cl, and so addition of 15NH4Cl to Sf9 media 
provided a potential method to isotopically enrich EGFP. Results were 
inconclusive because EGFP formed dimers or aggregated, and either form is too 
large to detect in cells by using the HSQC experiment. However, 15N enrichment 
was detected in the side chains of one or more cellular proteins, indicating that 
Sf9 cells use 15NH4Cl for protein production. These findings suggested that 15N 
enrichment of a disordered protein in Sf9 cells by these methods might yield 
successful protein in-cell NMR results. The NMR results for infected Sf9 cells 
producing α-syn and α-syn-EGFP in 15N-containing custom media were 
inconclusive. Similarity in the spectra of the Sf9 cell slurries producing α-syn, 
EGFP, and α-syn-EGFP in 15NH4Cl containing media and the absence of uniform 
enrichment of the proteins in 15N algal amino acid containing media suggests the 
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enrichment of other intracellular components. Therefore, the acquisition of 
disordered recombinant proteins in Sf9 cells by HSQC NMR is not possible under 
the current experimental conditions. Commerically available 15N-enriched 
Bioexpress-2000 media (Cambridge Isotope Laboratories, Inc.) was not utilized 
in these experiments. This media has been shown to uniformly enrich a 
recombinant protein (116) in insect cells. Thus, this media remains a potential, 
albeit expensive, candidate for future isotopic enrichment experiments.  
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3.5   List of Tables 
 
 
 
Table 3.1 pIEx-7 sequencing primers for target gene insert 
           Name                              Sequence 
 
IE1 Promoter Primer 5’ TGGATATTGTTTCAGTTGCAAG 3’ 
AS S-Tag Primer 5’ GTCCGTGTGCTGGCGTTC 3’ 
 
 
 
 
 
 
 
 
 
 
Table 3.2 Primers for PCR amplification of target genes into the pIEx-7 Ek/LIC 
vector 
 
Gene  Vector          Sequence (forward and reverse complement) 
 
α-Syn pT7-71 5’ GACGACGACAAGATGGATGTATTCATGAAAGGAC 3’ 
                                        5’ GAGGAGAAGCCCGGTTAGGCTTCAGGTTCGTAGTC 3’ 
Cytochrome c pBTR2 5’ GACGACGACAAGATGGGCGACGTGGAAAAAGGCA 3’ 
                                          5’ GAGGAGAAGCCCGGTTATCATTCGTTCGTCGCCTT 3’ 
AcGFP pAcGFP13 5’ GACGACGACAAGATGGTGAGCAAGGGCGCCGA 3’ 
                                          5’ GAGGAGAAGCCCGGTCACTTGTACAGCTCATCCAT 3’ 
Ubiquitin pASK4 5’ GACGACGACAAGATGGCAATCTTCGTCAAGACGTT 3’ 
                                         5’ GAGGAGAAGCCCGGTCAACCACCTCTTAGTCTTAA 3’ 
HSP27 pCMV6-AC5 5’ GACGACGACAAGATGACCGAGCGCCGCGTCCCCTT 3’ 
                                         5’ GAGGAGAAGCCCGGTTACTTGGCGGCAGTCTCATC 3’ 
 
1
 pT7-7 vector with the α-syn gene is from (18) 
2
 pBTR vector with the human cytochrome c gene is from (145) 
3
 pAcGFP1 is from Clontech Laboratories, Inc. (Mountain View, CA) 
4
 pASK-Ubq was provided by Alexander Shekhtman (146) 
5
 pCMV6-AC vector with the human HSP27 gene is from Origene Technologies, 
Inc. (Rockville, MD) 
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Table 3.3 pAcGFP1 primers for PCR amplification of the AcGFP gene 
         Name Sequence 
 
pAcGFP1 forward 5’ CCGGCTCGTATGTTGTGTGGAATTGTGAGCGGAT 3’ 
pAcGFP1 reverse 5’ TGTCAGAGGTTTTCACCGTCATCACCGAAACGCG 3’ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4 pUltraBac-1 mutagenesis primers to introduce BamHI and HindIII sites 
         Name                                        Sequence 
 
Forward HindIII 5’ CTCGTCTTGGTCGTTTGAAGCTTTGTTGCTGTGTTTCC 3’ 
Reverse HindIII 5’ GGAAACACAGCAACAAAGCTTCAAACGACCAAGACGAG 3’ 
Forward BamHI 5’ CACTGCTTGAGCCTAGGGGATCCGAACCAGATAAG 3’ 
Reverse BamHI 5’ CTTATCTGGTTCGGATCCCCTAGGCTCAAGCAGTG 3’ 
 
The HindIII and BamHI recognition sites are underlined 
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Table 3.5 Amounts of sugars, amino acids, and 15NH4Cl used to create custom 
media 
 
20 Individual A.A. Custom Media1 15NH4Cl Custom Media2 
 
Ingredient          Concentration (g/L) 
Glucose 4.81 3.60 
Galactose 1.20 1.20 
Mannose 2.16 2.16 
Fructose 0.38 0.38 
Sucrose 1.75 1.75 
  
         Concentration (mg/L) 
Aspartate 28.5 159 
Glutamate 372 2446 
Asparagine 201 359 
Serine 11.1 185 
Glutamine 999 0 
Glycine 18.6 117 
Histidine 1.8 178 
Arginine 14.4 381 
Threonine 14.7 204 
Alanine 354 251 
Proline 15 338 
Tyrosine 6.6 303 
Valine 22.5 607 
Methionine 6.3 902 
Cysteine 201 100 
Isoleucine 18.9 762 
Leucine 324 632 
Phenylalanine 9.3 597 
Lysine 21.3 193 
Tryptophan 2013, 4 100 
15NH4Cl - 800 
 
1 Amino acid content mimics 3 g/L algal amino acid mix (113) 
2 Amino acid content mimics commercial ESF 921 media (113) except no 
glutamine was added, an additional 2 g/L glutamate was added, and cysteine 
and tryptophan were added at 100 mg/L  
3 Tryptophan was omitted in 19 individual A.A. custom media 
4 All amino acids were omitted in no A.A. custom media 
Custom media components were added to ESF NMR media 
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Table 3.6 15N-enriched custom IPL-41 media 
                Ingredient Concentration1 (mg/L) 
 
Biotin 0.16 
Choline chloride 20 
D-Calcium pantothenate 0.008 
Folic Acid 0.08 
Nicotinic acid  0.16 
Para-Aminobenzoic acid 0.32 
Pyridoxine hydrochloride 0.4 
Riboflavin 0.08 
Succinic acid 4.8 
Thiamine hydrochloride 0.08 
Vitamin B12 0.24 
Isoinositol 0.4 
(NH4)6Mo7O24·4H20 0.04 
CaCl2  500 
CoCl2·6H2O 0.05 
CuCl2·2H2O 0.2 
FeSO4·7H2O 0.55 
MgSO4  918 
MnCl2·4H2O 0.02 
KCl 1200 
NaHCO3 350 
NaCl 2850 
NaH2PO4·H2O 1160 
ZnCl2 0.04 
α-Ketoglutaric acid 29.6 
D-Glucose 2500 
Fumaric acid 4.4 
Malic acid 53.6 
Maltose 1000 
Sucrose 1650 
Cysteine 120 
Tryptophan 100 
Glutamine 1000 
Asparagine 1300 
15N-enriched algal amino acid mix 1000 
Chemically Defined Lipid Concentrate, 100x 1% (v/v) 
Yeastolate Ultrafiltrate, 50x 4% (v/v)2 
 
1 The media components are listed at their final concentrations in deionized 
water. Cysteine, tryptophan, glutamine, and asparagine were added at the 
concentrations present in the IPL-41 formulation recipe (Invitrogen Corp.) 
2
 
15N-enriched custom IPL-41 media were prepared with or without Yeastolate 
Ultrafiltrate, 50x 
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Table 3.7 Viabilities and α-syn production in Sf9 cells infected with α-syn 
pFastBac 1 recombinant baculovirus 1-8 days p.i.   
 
   Day p.i.       Viability (%)1                        α-Syn Concentration (µM)2 
                                           2 x 106 cells/mL    2.6 x 108 cells/mL      Intracellular 
1 92 ±5 0.28 ±0.02 36 ±2 79 ±5 
2 87 ±6 0.29 ±0.05 37 ±7 81 ±14 
3 63 ±6 2.3 ±1.0 293 ±130 637 ±283 
4 57 ±3 3.4 ±0.2 447 ±31 973 ±68 
5 39 ±6 3.4 ±0.5 440 ±64 958 ±139 
6 31 ±12 1.9 ±0.1 250 ±17 545 ±37 
7 26 ±16 0.45 ±0.04 58 ±5 126 ±11 
8 15 ±14 0.40 ±0.03 52 ±4 113 ±9 
 
1
 Sf9 viability prior to infection was 93 ±3% 
2
 Estimated concentrations calculated as described in 3.3.2 
The uncertainty is the standard error of three separate experiments 
 
 
 
Table 3.8 Recombinant protein yields from Sf9 cells 48 h post transfection with 
pIEx-7 vectors 
 
    Protein Number of Measurements Yield1 (mg/L) Viability 
 
Mock Infected 2       0 81 ±1 
α-Syn 2 1.3 ±0.1 33 ±1 
Cytochrome c 3 0.5 ±0.1 48 ±9 
AcGFP 5 1.5 ±0.2 33 ±7 
Ubiquitin 2 0.7 ±0.1 37 ±6 
HSP27 4 2.7 ±0.4 44 ±4 
 
1
 Protein yields normalized to 2 x 106 cells/mL and reported with standard errors 
 
 
Table 3.9 Viabilities and EGFP concentrations in Sf9 cells infected with 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus in commercial ESF 921 
media   
 
   Hours p.i.    Viability (%)1                    EGFP Concentration (µM)2 
                                          2 x 106 cells/mL    2.6 x 108 cells/mL      Intracellular 
48 85 2.1 278 604 
72 54 2.2 282 614 
 
1
 Sf9 viability prior to infection was 96% 
2
 Estimated concentrations calculated as described in 3.3.2 
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Table 3.10 Viabilities and EGFP concentrations in Sf9 cells infected with 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus in custom media   
 
Hours p.i.     ESF 921  Algal Media   Algal+5% ESF 921   20 A.A. Media   20 A.A.+5% ESF 921 
                                                    Viability (%)1 
48 95 89 92 96 93 
72 86 61 56 55 61 
                                Concentration, 2 x 106 cells/mL (µM)2 
48 1.88 1.75 1.89 1.63 1.42 
72 2.49 1.83 1.81 1.44 1.43 
                              Concentration, 2.6 x 108 cells/mL (µM) 
48 244 228 246 212 185 
72 324 238 235 187 186 
                                   Intracellular Concentration (µM) 
48 533 496 535 461 402 
72 703 518 512 408 405 
 
1
 Sf9 viability prior to infection was 98% 
2
 Estimated concentrations calculated as described in 3.3.2 
 
 
 
 
 
 
Table 3.11 Viabilities and EGFP concentrations in Sf9 cells infected with 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus in 5-FW custom algal media  
 
                               ESF 921 Media                         5-FW Custom Algal Media 
 
Viability (%) [EGFP] (µM) Viability (%) [EGFP] (µM) 
Initial 91 n.d. 94 n.d 
24 h p.i. 99 0.851/1112/2393 97 0.69/90/195 
48 h p.i. 88 1.94/252/549 87 1.41/183/398 
72 h p.i. 72 2.04/265/578 59 1.18/153/333 
 
n.d. = not determined 
1
 EGFP concentration at 2 x 106 cells/mL 
2
 EGFP concentration at 2.6 x 108 cells/mL 
3
 EGFP intracellular concentration  
Estimated concentrations calculated as described in 3.3.2 
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Table 3.12 Viabilities and EGFP concentrations in Sf9 cells infected with 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus in variable yeastolate 
custom algal media  
 
                        0% Yeastolate              2% Yeastolate             10% Yeastolate    
  
              Viability (%) 
Initial 99 99 99 
24 h p.i. 96 95 97 
48 h p.i. 87 84 93 
72 h p.i. 54 60 74 
 
                              [EGFP] (µM) 
 
24 h p.i. 0.551/722/1553 0.47/61/134 0.29/38/81 
48 h p.i. 1.46/190/414 1.44/187/408 0.94/122/267 
72 h p.i. 1.31/170/372 1.41/183/398 1.13/147/318 
 
1
 EGFP concentration at 2 x 106 cells/mL 
2
 EGFP concentration at 2.6 x 108 cells/mL 
3
 EGFP intracellular concentration  
Estimated concentrations calculated as described in 3.3.2 
 
 
 
 
 
Table 3.13 Viabilities and EGFP concentrations in Sf9 cells infected with 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus in “no yeastolate” custom 
algal media 
 
               “No Yeastolate, No Tryptophan”       “No Yeastolate” and 0.1 g/L Tryptophan    
             Viability (%)      [EGFP] (µM)             Viability (%)     [EGFP] (µM) 
48 h p.i.  96 1.651/2152/4673 94 2.08/270/589 
72 h p.i.  84  1.77/230/502 79 2.59/337/734 
 
1
 EGFP concentration at 2 x 106 cells/mL 
2
 EGFP concentration at 2.6 x 108 cells/mL 
3
 EGFP intracellular concentration  
Estimated concentrations calculated as described in 3.3.2 
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Table 3.14 Viabilities of Sf9 cells infected with pUltraBac-1-hsp70-AcGFP 
recombinant baculovirus in 20 individual A.A., 19 individual A.A., and no A.A. 
custom media 
 
                 20 Individual A.A.             19 Individual A.A.                         No A.A. 
                    Viability (%) 
24 h p.i.              91                                       89                                          83       
48 h p.i.              86                                       85                                          82       
 
 
Table 3.15 Viabilities and recombinant protein concentrations in Sf9 cells 
infected with α-syn pUltraBac-1 or α-syn-EGFP pUltraBac-1 recombinant 
baculovirus in commercial ESF 921 media   
 
       α-Syn pUltraBac-1 Baculovirus                  α-Syn-EGFP pUltraBac-1 Baculovirus                                  
 
Viability Conc. (µM)            Viability  Conc. (µM) Conc. (µM) Conc. (µM) 
 
(%) (western blot)          (%) (fluorescence) (western blot) (average) 
Initial 96 n.d.        96           n.d. n.d. n.d. 
48 h p.i. 90 4.341/5652/12103 94  18.0/2340/5000 14.3/1860/3970 16.2/2100/4490 
72 h p.i. 74 3.30/429/916 74  18.3/2380/5080 14.9/1940/4150 16.6/2160/4610 
 
n.d. = not determined 
1
 estimated protein concentration at 2 x 106 cells/mL 
2
 estimated protein concentration at 2.6 x 108 cells/mL 
3
 estimated intracellular protein concentration  
 
 
 
Table 3.16 Viabilities and fluorescence of Sf9 cells infected with α-syn pUltraBac-
1 and α-syn-EGFP pUltraBac-1 recombinant baculoviruses in 15N-enriched 
custom media for in-cell NMR   
 
                                     15NH4Cl Media      15N-Enriched IPL-41 Media    15N-Phe Media 
                       α-Syn   α-Syn-EGFP   α-Syn-EGFP  α-Syn-EGFP    α-Syn  α-Syn-EGFP 
                                                         - Yeastolate    + Yeastolate 
            Viability (%) 
0 h p.i.               99 99 100 94 99 100 
43-44 h p.i.        96 96 98 90 98 98 
Fluoroscence1    No 24% Yes Yes No Yes 
 
1 Percent fluorescing cells was determined only for Sf9 cells infected with α-syn-
EGFP pUltraBac-1 recombinant baculovirus in 15NH4Cl custom media. Nearly all 
cells fluoresced green in the samples labeled “Yes” as observed under the 
microscope.  
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3.6   List of Figures  
 
 
 
 
Figure 3.1 HSQC spectra of wild-type α-syn a) in dilute solution at 10 ° C, b) 
dilute solution at 35 ° C, c) in E. coli at 35 ° C, and d) in a 300 g/L solution of 
bovine serum albumin at 35 ° C. Images adapted from ( 18).  
 
 
 
 
 
 
a) 
b) 
c) 
d) 
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Figure 3.2 pFastBac Dual vector map (Invitrogen Corp.). After transposition into 
a baculovirus bacmid and insect cell transfection, this vector allows coexpression 
of two genes under the control of the polyhedrin (PH) and p10 promoters. 
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Figure 3.3 Fluorescence images of Sf9 cells infected with EGFP pFastBac Dual 
recombinant baculovirus. a) Fluorescence image of Sf9 cells 8 days p.i. b) 
Fluorescence and transmitted light overlay of Sf9 cells 8 days p.i. c) 
Fluorescence image of uninfected Sf9 cells. d) Fluorescence and transmitted 
light overlay of uninfected Sf9 cells. Images were acquired with the Zeiss 510 
Meta Laser Scanning Confocal Microscope using a 488 nm excitation 
wavelength. 
 
 
 
a)             b) 
c)             d) 
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Figure 3.4 SDS-PAGE images of whole cell lysates from Sf9 cells infected with 
EGFP pFastBac Dual recombinant baculovirus visualized with a) Brilliant Blue 
staining and b) fluorescence. Lane 1 contains an EGFP positive control, lanes 2-
3 contain spent media (to detect protein leakage), and lanes 4-7 contain identical 
whole cell lysates. Lane identifications are the same in a) and b). 
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Figure 3.5 pFastBac 1 vector map (Invitrogen Corp.). After transposition into a 
baculovirus bacmid and insect cell transfection, this vector allows expression of 
the gene of interest under the control of the PH promoter.  
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Figure 3.6 Western blot of whole cell lysates of Sf9 cells infected with α-syn 
pFastBac 1 recombinant baculovirus. Lanes 1 and 11 contain α-syn positive 
controls (each lane loaded with 1.9 µg). Lane 2 contains uninfected Sf9 whole 
cell lysate. Lanes 3-10 correspond to infected Sf9 suspension cells harvested 1-8 
days p.i., respectively. 
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Figure 3.7 Sf9 cell growth in custom media. a) Cell growth in custom media and 
commercial ESF 921 medium. b) Expanded view of Sf9 cell growth in custom 
media only.  
 
 
a) 
b) 
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Figure 3.8 Sf9 cell viability in custom media.  
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Figure 3.9 a) Growth and b) viability of α-syn pFastBac 1 recombinant 
baculovirus infected Sf9 cells in custom media.  
 
 
a) 
b) 
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Figure 3.10 Western blot of whole cell lysates of Sf9 cells infected with α-syn 
pFastBac 1 recombinant baculovirus of known titer at a MOI of 3 in custom 
media containing larger amounts of yeastolate and glucose (see 3.2.4). Lanes 2, 
4, 6, and 8 are loaded with increasing amounts of whole cell lysate 72 h p.i. 
Lanes 3, 5, 7, and 9 are loaded with increasing amounts of whole cell lysate 96 h 
p.i. Lanes 1 and 10 are α-syn controls (each lane loaded with 1.9 µg). 
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Figure 3.11 pIEx-7 Ek/LIC vector map (EMD Biosciences, Inc.). The vector 
employs an hr5 enhancer and IE1 promoter combination to recruit endogenous 
insect cell transcription machinery to directly produce the recombinant protein of 
interest. The vector employs ligation-independent cloning to insert genes, 
enabling quick screening of multiple targets.  
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Figure 3.12 SDS-PAGE results for recombinant human HSP27 purified from 
pIEx-7 HSP27 transfected Sf9 cells using the InsectDirect transfection system. 
Lanes 1, 3, and 5 contain identical lysates of pIEx-7 HSP27 transfected Sf9 cells. 
Lanes 2, 4, and 6 contain identical samples of Ni-NTA purified HSP27. The 
monomer runs at about 27 kDa while a higher molecular weight product runs at 
about 60 kDa. 
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Figure 3.13 SDS-PAGE results for recombinant AcGFP purified from Sf9 cells 
transfected with pIEx-7 AcGFP. Lane 1 contains the AcGFP control, lanes 2-3 
contain Ni-NTA purified AcGFP, and lanes 4-5 contain whole cell lysates. a) 
Brilliant Blue staining. b) Fluorescence detection prior to Brilliant Blue staining. 
Lane identifications are the same in a) and b). 
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Figure 3.14 pUAST vector map. This vector contains a Drosophila hsp70 
promoter. Image adapted from the Drosophila Genomics Resource Center 
(http://dgrc.cgb.indiana.edu). 
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Figure 3.15 pUltraBac-1 vector map. This vector contains the EGFP gene under 
the control of the lepidopteran active late basic protein promoter (PBasic) to allow 
fast titering of recombinant baculoviruses in Sf9 insect cells. Adapted from (133). 
 
141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 Fluorescence SDS-PAGE results showing EGFP production in Sf9 
cells infected with pUltraBac-1-hsp70-AcGFP recombinant baculovirus in 
commercial ESF 921 media. The four GFP control lanes correspond to 1, 2, 4, 
and 8 µg of GFP. Forty-eight h p. i. and 72 h p.i. correspond to Sf9 whole cell 
lysates harvested 48 h and 72 h p.i. and loaded in triplicate in increasing 
amounts.  
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Figure 3.17 Fluorescence SDS-PAGE results showing EGFP production in Sf9 
cells infected with pUltraBac-1-hsp70-AcGFP recombinant baculovirus in custom 
media. The four GFP control lanes correspond to 1, 2, 4, and 8 µg of GFP. Forty-
eight h p.i. and 72 h p.i. correspond to Sf9 whole cell lysates harvested 48 h and 
72 h p.i. and loaded in triplicate in increasing amounts.  
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Figure 3.18 19F spectra of pUltraBac-1-hsp70-AcGFP recombinant baculovirus 
infected Sf9 cells producing EGFP in 5-FW custom algal medium 48 h p.i. a) 
Spectrum of the cell slurry. b) Spectrum of the Sf9 cleared lysate.  
 
 
 
 
 
 
a) 
 
 
 
 
 
 
 
 
b) 
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Figure 3.19 HSQC spectra of pUltraBac-1-hsp70-AcGFP recombinant 
baculovirus infected Sf9 cells producing EGFP in 15NH4Cl custom medium. a) 
Spectrum of the cell slurry 48 h p.i. b) Spectrum of the Sf9 cleared lysate 96 h p.i.  
 
a)  
 
 
 
b)  
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Figure 3.20 SDS-PAGE results of EGFP purified by size exclusion 
chromatography from lysates of Sf9 cells infected with pUltraBac-1-hsp70-
AcGFP recombinant baculovirus and harvested 48 h p.i. Cells were grown in 
15NH4Cl custom media. Lanes 1-6, 7-11, and 12-17 contain fractions from three 
separate purifications. Fractions containing EGFP were pooled.  
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Figure 3.21 HSQC spectra of purified EGFP from Sf9 cells infected with 
pUltraBac-1-hsp70-AcGFP recombinant baculovirus in a) 20 mM sodium 
phosphate buffer, pH 6.0, and in b) 200 mM NaCl, 20 mM sodium phosphate 
buffer, pH 6.0.  
a)  
 
 
 
b)  
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Figure 3.22 Detection of α-syn and α-syn-EGFP from whole cell lysates of Sf9 
cells infected with α-syn pUltraBac-1 or α-syn-EGFP pUltraBac-1 recombinant 
baculoviruses in commercial ESF 921 media. a) Fluorescence image of SDS 
polyacrylamide gel for detection of EGFP. Lane 1 contains 1.9 µg α-syn positive 
control. Lanes 2-4 contain AcGFP positive controls loaded at 2, 4, and 8 µg. 
Lanes 5 and 6 contain lysates of Sf9 cells infected with α-syn pUltraBac-1 
recombinant baculovirus and harvested 48 h and 72 h p.i., respectively. Lanes 7 
and 8 contain lysates of Sf9 cells infected with α-syn-EGFP pUltraBac-1 
recombinant baculovirus and harvested 48 h and 72 h p.i., respectively. b) 
Western blot of gel imaged in a) to detect the presence of α-syn. Lane 
identifications are the same as in a). 
  
 
 
 
20 kDa 
27 kDa 
a) 
b) 
α-syn-EGFP 
α-syn-EGFP 
α-syn 
    1   2   3    4   5    6    7    8 
    1   2   3    4   5    6     7    8 
148 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23 HSQC spectra of Sf9 cells infected with α-syn pUltraBac-1 or α-syn-
EGFP pUltraBac-1 recombinant baculoviruses and grown in 15NH4Cl custom 
media. a) Spectrum of the α-syn pUltraBac-1 recombinant baculovirus infected 
cell slurry 43 h p.i. b) Lysate of the spectrum shown in a). c) Spectrum of the α-
syn-EGFP pUltraBac-1 recombinant baculovirus infected cell slurry 43 h p.i. d) 
Lysate of the spectrum shown in c).  
 
 
 
 
a) b) 
c) d) 
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Figure 3.24 HSQC spectra of Sf9 cells infected with α-syn-EGFP pUltraBac-1 
recombinant baculovirus and grown in 15N-enriched custom IPL-41 media without 
yeastolate. a) Spectrum of the cell slurry 44 h p.i. b) Lysate of the spectrum 
shown in a).  
a) 
b) 
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Figure 3.25 HSQC spectrum of Sf9 cells infected with α-syn pUltraBac-1 
recombinant baculovirus and grown in 15N-phenylalanine custom medium. The 
spectrum of the cell slurry was acquired 44 h p.i.  
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